PL1641915T3 - Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo - Google Patents

Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo

Info

Publication number: PL1641915T3
Authority: PL; Poland
Prior art keywords: postpartum; regeneration; repair; derived cells; ocular tissue
Prior art date: 2003-06-27

Application number

PL04777234T

Other languages

English (en)

Inventor

Sanjay Mistry

Darin J. Messina

Ian Ross Harris

Alexander M. Harmon

Anthony J. Kihm

Agnieszka Seyda

Chin-Feng Yi

Anna Gosiewska

Original Assignee

DePuy Synthes Products, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-27

Filing date

2004-06-25

Publication date

2017-01-31

2004-06-25 Application filed by DePuy Synthes Products, Inc. filed Critical DePuy Synthes Products, Inc.

2017-01-31 Publication of PL1641915T3 publication Critical patent/PL1641915T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Neurology (AREA)
Cell Biology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Psychology (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)

PL04777234T 2003-06-27 2004-06-25 Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo PL1641915T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US48326403P	2003-06-27	2003-06-27

Publications (1)

Publication Number	Publication Date
PL1641915T3 true PL1641915T3 (pl)	2017-01-31

Family

ID=38456561

Family Applications (14)

Application Number	Title	Priority Date	Filing Date
PL04777287T PL1641918T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
PL04777234T PL1641915T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo
PL10183911T PL2341131T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanki chrzęstnej i kostnej z wykorzystaniem komórek uzyskanych po porodzie
PL10184306T PL2338982T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10184221T PL2338981T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek pochodzących z pępowiny poporodowej
PL04777286.8T PL1641917T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek miękkich przy zastosowaniu komórek pozyskiwanych poporodowo
PL10184796T PL2336298T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04809466T PL1649013T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych
PL10184137T PL2338980T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem poporodowych komórek pępowinowych
PL04777231T PL1641914T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04777235T PL1641916T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych
PL04756395T PL1641913T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10183053T PL2399990T3 (pl)	2003-06-27	2004-06-25	Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia
PL10184593T PL2322599T3 (pl)	2003-06-27	2004-06-25	Komórki pozyskiwane poporodowo z tkanki sznura pępowinowego i sposoby pozyskiwania i zastosowania tych komórek do naprawy i regeneracji tkanek miękkich

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL04777287T PL1641918T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia

Family Applications After (12)

Application Number	Title	Priority Date	Filing Date
PL10183911T PL2341131T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanki chrzęstnej i kostnej z wykorzystaniem komórek uzyskanych po porodzie
PL10184306T PL2338982T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10184221T PL2338981T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek pochodzących z pępowiny poporodowej
PL04777286.8T PL1641917T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek miękkich przy zastosowaniu komórek pozyskiwanych poporodowo
PL10184796T PL2336298T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04809466T PL1649013T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych
PL10184137T PL2338980T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem poporodowych komórek pępowinowych
PL04777231T PL1641914T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04777235T PL1641916T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych
PL04756395T PL1641913T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10183053T PL2399990T3 (pl)	2003-06-27	2004-06-25	Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia
PL10184593T PL2322599T3 (pl)	2003-06-27	2004-06-25	Komórki pozyskiwane poporodowo z tkanki sznura pępowinowego i sposoby pozyskiwania i zastosowania tych komórek do naprawy i regeneracji tkanek miękkich

Country Status (8)

Country	Link
US (28)	US7560276B2 (pl)
EP (14)	EP2399990B1 (pl)
JP (7)	JP4948164B2 (pl)
AU (7)	AU2004252567B2 (pl)
CA (7)	CA2530422C (pl)
ES (14)	ES2564044T3 (pl)
PL (14)	PL1641918T3 (pl)
WO (7)	WO2005001078A2 (pl)

Families Citing this family (574)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8563232B2 (en)	2000-09-12	2013-10-22	Lifenet Health	Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US20080077251A1 (en) *	1999-06-07	2008-03-27	Chen Silvia S	Cleaning and devitalization of cartilage
US20020095157A1 (en) *	1999-07-23	2002-07-18	Bowman Steven M.	Graft fixation device combination
US6179840B1 (en)	1999-07-23	2001-01-30	Ethicon, Inc.	Graft fixation device and method
US8147824B2 (en)	1999-08-05	2012-04-03	Athersys, Inc.	Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
EP1349918B1 (en) *	2000-12-06	2014-08-06	Anthrogenesis Corporation	Method of collecting placental stem cells
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
CA2365376C (en)	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CA2856986C (en) *	2001-02-14	2019-08-13	Anthrogenesis Corporation	Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
ES2558626T3 (es) *	2001-02-14	2016-02-05	Anthrogenesis Corporation	Placenta post-parto de mamíferos, su uso y células madre placentarias de la misma
IL159895A0 (en) *	2001-07-20	2004-06-20	Technion Res & Dev Foundation	Methods of generating human cardiac cells and tissues and uses thereof
US7677565B2 (en)	2001-09-28	2010-03-16	Shuffle Master, Inc	Card shuffler with card rank and value reading capability
US7736892B2 (en) *	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
US20080299090A1 (en) *	2002-02-25	2008-12-04	Kansas State University Research Foundation	Use Of Umbilical Cord Matrix Cells
US20080003258A1 (en) *	2002-10-16	2008-01-03	Marcum Frank D	Composition and Method for Treating Rheumatoid Arthritis
US20040078090A1 (en)	2002-10-18	2004-04-22	Francois Binette	Biocompatible scaffolds with tissue fragments
US7824701B2 (en)	2002-10-18	2010-11-02	Ethicon, Inc.	Biocompatible scaffold for ligament or tendon repair
BR0316695A (pt)	2002-11-26	2005-10-18	Anthrogenesis Corp	Unidade citoterapêutica, kit para tratamento, método de tratamento de uma enfermidade, biblioteca de unidades citoterapêuticas e método de tratamento de um paciente
US7807458B2 (en)	2003-01-30	2010-10-05	The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs	Multilineage-inducible cells and uses thereof
EP2277992A3 (en)	2003-02-11	2011-03-02	John E. Davies	Progenitor cells from Wharton's jelly of human umbilical cord
BRPI0407427A (pt) *	2003-02-13	2006-01-24	Anthrogenesis Corp	Método para tratar um paciente e para tratar a mielodisplasia
US8197837B2 (en)	2003-03-07	2012-06-12	Depuy Mitek, Inc.	Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
EP1620827B1 (en) *	2003-04-24	2010-06-02	Koninklijke Philips Electronics N.V.	Non-invasive left ventricular volume determination
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US8491883B2 (en) *	2003-06-27	2013-07-23	Advanced Technologies And Regenerative Medicine, Llc	Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US9592258B2 (en)	2003-06-27	2017-03-14	DePuy Synthes Products, Inc.	Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
ES2564044T3 (es)	2003-06-27	2016-03-17	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
US8518390B2 (en)	2003-06-27	2013-08-27	Advanced Technologies And Regenerative Medicine, Llc	Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US7875272B2 (en) *	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
US8226715B2 (en)	2003-06-30	2012-07-24	Depuy Mitek, Inc.	Scaffold for connective tissue repair
US10583220B2 (en)	2003-08-11	2020-03-10	DePuy Synthes Products, Inc.	Method and apparatus for resurfacing an articular surface
NZ545702A (en) *	2003-08-12	2008-08-29	Tigenix Nv	Use of CXCL6 chemokine in the prevention or repair of cartilage defects
US8043614B2 (en)	2004-03-09	2011-10-25	Ahlfors Jan-Eric W	Autogenic living scaffolds and living tissue matrices: methods and uses thereof
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
US7682828B2 (en)	2003-11-26	2010-03-23	Whitehead Institute For Biomedical Research	Methods for reprogramming somatic cells
US7316822B2 (en)	2003-11-26	2008-01-08	Ethicon, Inc.	Conformable tissue repair implant capable of injection delivery
CA2547570A1 (en) *	2003-12-02	2005-06-23	Celgene Corporation	4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for induction of fetal hemoglobin in individuals having anemia
US7901461B2 (en) *	2003-12-05	2011-03-08	Ethicon, Inc.	Viable tissue repair implants and methods of use
JP2005168360A (ja) *	2003-12-09	2005-06-30	Olympus Corp	生体組織補填体の検査方法、装置、細胞培養容器および培養状態検査方法
US20050176139A1 (en) *	2004-01-12	2005-08-11	Yao-Chang Chen	Placental stem cell and methods thereof
WO2005071066A1 (en) *	2004-01-23	2005-08-04	Board Of Regents, The University Of Texas System	Methods and compositions for preparing pancreatic insulin secreting cells
US11395865B2 (en)	2004-02-09	2022-07-26	DePuy Synthes Products, Inc.	Scaffolds with viable tissue
EP2298862B1 (en)	2004-03-22	2017-08-30	Mesoblast International Sàrl	Mesenchymal stem cells and uses therefor
US8221780B2 (en) *	2004-04-20	2012-07-17	Depuy Mitek, Inc.	Nonwoven tissue scaffold
US8137686B2 (en)	2004-04-20	2012-03-20	Depuy Mitek, Inc.	Nonwoven tissue scaffold
WO2005108559A2 (en) *	2004-04-23	2005-11-17	Bioe, Inc.	Multi-lineage progenitor cells
US7622108B2 (en) *	2004-04-23	2009-11-24	Bioe, Inc.	Multi-lineage progenitor cells
WO2005107807A2 (en) *	2004-05-06	2005-11-17	University Of South Florida	Cerebral intraventricular transplantation as method of treating amyotrophic lateral sclerosis
US20060083732A1 (en) *	2004-06-30	2006-04-20	Arlene Gwon	Hyaluronic acid in the enhancement of lens regeneration
US8802651B2 (en) *	2004-06-30	2014-08-12	Abbott Medical Optics Inc.	Hyaluronic acid in the enhancement of lens regeneration
US7794697B2 (en)	2004-06-30	2010-09-14	Abbott Medical Optics Inc.	Enhancement of lens regeneration using materials comprising polysiloxane polymers
PL1789534T3 (pl)	2004-08-16	2015-03-31	Cellresearch Corp Pte Ltd	Wyodrębnienie komórek macierzystych/progenitorowych z błony owodniowej pępowiny
US20060045872A1 (en)	2004-08-25	2006-03-02	Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco	Use of adipose tissue-derived stromal stem cells in treating fistula
US20060069008A1 (en) *	2004-09-28	2006-03-30	Sanjay Mistry	Treatment of neurological deficits in the striatum or substanta nigra pars compacta
US8039258B2 (en) *	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US20080038316A1 (en) *	2004-10-01	2008-02-14	Wong Vernon G	Conveniently implantable sustained release drug compositions
US7473678B2 (en)	2004-10-14	2009-01-06	Biomimetic Therapeutics, Inc.	Platelet-derived growth factor compositions and methods of use thereof
US7842304B2 (en) *	2004-10-29	2010-11-30	Nexeon Medsystems, Inc.	Methods and apparatus for treating an injured nerve pathway
US11660317B2 (en)	2004-11-08	2023-05-30	The Johns Hopkins University	Compositions comprising cardiosphere-derived cells for use in cell therapy
US8017395B2 (en) *	2004-12-17	2011-09-13	Lifescan, Inc.	Seeding cells on porous supports
WO2006101548A2 (en) *	2004-12-21	2006-09-28	Ethicon, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060153815A1 (en) *	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
WO2006083394A2 (en) *	2004-12-21	2006-08-10	Ethicon, Inc.	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
WO2006071778A2 (en)	2004-12-23	2006-07-06	Ethicon Incorporated	Treatment of parkinson's disease and related disorders using postpartum derived cells
EP1831355A2 (en) *	2004-12-23	2007-09-12	Ethicon, Inc.	Soft tissue repair and regeneration using postpartum-derived cells and cell products
ES2621847T3 (es) *	2004-12-23	2017-07-05	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
EP1838842A2 (en) *	2004-12-23	2007-10-03	Ethicon, Incorporated	Treatment of osteochondral diseases using postpartum-derived cells and products thereof
US20060182724A1 (en) *	2005-02-15	2006-08-17	Riordan Neil H	Method for expansion of stem cells
CA2600653C (en)	2005-03-04	2014-09-09	Kyoto University	Pluripotent stem cell derived from cardiac tissue
US8153430B2 (en) *	2005-03-31	2012-04-10	Stemnion, Inc.	Methods related to surgery
US20060222634A1 (en)	2005-03-31	2006-10-05	Clarke Diana L	Amnion-derived cell compositions, methods of making and uses thereof
EP2460875A1 (en)	2005-03-31	2012-06-06	Stemnion, Inc.	Amnion-derived cell compositions, methods of making and uses thereof
WO2006110806A2 (en) *	2005-04-12	2006-10-19	The Trustees Of The University Of Pennsylvania	Multipotent adult stem cells
WO2006113731A2 (en) *	2005-04-20	2006-10-26	University Of Florida Research Foundation, Inc.	Bone marrow-derived neurogenic cells and uses thereof
US20100087546A1 (en) *	2005-04-20	2010-04-08	Biogenic Innovations, Llc	Use of dimethyl sulfone (msm) to reduce homocysteine levels
EP1879606B1 (en) *	2005-04-25	2013-06-12	Massachusetts Institute of Technology	Self-assembling peptides for promoting hemostasis
AU2006202209B2 (en) *	2005-05-27	2011-04-14	Lifescan, Inc.	Amniotic fluid derived cells
PT1888123E (pt) *	2005-06-08	2013-03-13	Janssen Biotech Inc	Uma terapêutica celular para a degeneração ocular
GB0511723D0 (en) *	2005-06-09	2005-07-13	Smith & Nephew	Placental stem cells
WO2006135899A2 (en) *	2005-06-13	2006-12-21	The Johns Hopkins University	Survival, differentiation and structural intergration of human neural stem cells grafted into the adult spinal cord
RU2284190C1 (ru) *	2005-06-14	2006-09-27	Дмитрий Дмитриевич Генкин	Способ лечения ишемической болезни сердца, или инфаркта миокарда и его последствий, или ишемии мозга, вызванной атеросклерозом или острым нарушением мозгового кровообращения, и ее последствий, или ишемии нижних конечностей, вызванной атеросклерозом
US7838503B2 (en) *	2005-06-15	2010-11-23	Children's Medical Center Corporation	Methods for extending the replicative lifespan of cells
US20140336514A1 (en) *	2005-08-05	2014-11-13	Gholam A. Peyman	Methods to regulate polarization and enhance function of cells
US20150119794A1 (en) *	2005-08-05	2015-04-30	Gholam A. Peyman	Methods to regulate polarization and enhance function of cells
US8435224B2 (en)	2005-09-12	2013-05-07	Abela Pharmaceuticals, Inc.	Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US7955418B2 (en)	2005-09-12	2011-06-07	Abela Pharmaceuticals, Inc.	Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same
US8480797B2 (en)	2005-09-12	2013-07-09	Abela Pharmaceuticals, Inc.	Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
EP2324838A1 (en)	2005-09-12	2011-05-25	Abela Pharmaceuticals, Inc.	Compositions Comprising Dimethyl Sulfoxide (DMSO)
JP2007106760A (ja) *	2005-09-16	2007-04-26	Kenji Yoshida	造血幹細胞増殖剤
EP3184630B1 (en)	2005-09-23	2019-07-17	TiGenix, S.A.U.	Cell populations having immunoregulatory activity, method for isolation and uses
EP1933852B1 (en)	2005-09-27	2018-12-19	TissueTech, Inc.	Amniotic membrane preparations and purified compositions and methods of use
EP1957633B1 (en)	2005-10-13	2013-12-18	Anthrogenesis Corporation	Immunomodulation using placental stem cells
US8071376B2 (en) *	2005-10-13	2011-12-06	Anthrogenesis Corporation	Production of oligodendrocytes from placenta-derived stem cells
JP4921767B2 (ja) *	2005-10-14	2012-04-25	株式会社カネカ	細胞の分化誘導方法
US11000546B2 (en)	2005-11-09	2021-05-11	Athersys, Inc.	Immunomodulatory properties of MAPCs and uses thereof
US10117900B2 (en) *	2005-11-09	2018-11-06	Athersys, Inc.	MAPC treatment of brain injuries and diseases
US20070178067A1 (en) *	2005-11-09	2007-08-02	John Maier	System and method for cytological analysis by raman spectroscopic imaging
WO2007059084A2 (en) *	2005-11-14	2007-05-24	The New England Medical Center Hospitals, Inc.	Methods for preparing cord matrix stem cells (cmsc) for long term storage and for preparing a segment of umbilical cord for cryopreservation
EP1951327A2 (en) *	2005-11-17	2008-08-06	Biomimetic Therapeutics, Inc.	Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
EP1971681B1 (en) *	2005-12-16	2017-08-23	DePuy Synthes Products, Inc.	Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US8741638B2 (en) *	2005-12-19	2014-06-03	DePuy Synthes Products, LLC	In vitro expansion of postpartum-derived cells in roller bottles
EP1976980B1 (en) *	2005-12-22	2019-03-06	Jane Ennis	Viable cells from frozen umbilical cord tissue
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
JP5599568B2 (ja) *	2005-12-28	2014-10-01	エシコン・インコーポレイテッド	分娩後由来細胞を用いた末梢血管疾患の治療
CN105106239A (zh) *	2005-12-28	2015-12-02	伊西康公司	使用产后衍生细胞治疗外周血管疾病
EP2471907B1 (en) *	2005-12-29	2018-09-26	Celularity, Inc.	Placental stem cell populations
JP2009521930A (ja)	2005-12-29	2009-06-11	アントフロゲネシスコーポレーション	胎盤幹細胞及び第２供給源由来幹細胞の共存培養
US9598669B2 (en) *	2005-12-29	2017-03-21	Anthrogenesis Corporation	Composition for collecting placental stem cells and methods of using the composition
EP1981970A4 (en)	2006-01-11	2009-10-21	Technion Res & Dev Foundation	TISSUE CONSTRUCTION TISSUE TREATMENT DERIVED FROM A HUMAN EMBRYONIC STEM CELL
US20070253931A1 (en) *	2006-01-12	2007-11-01	Osiris Therapeutics, Inc.	Use of mesenchymal stem cells for treating genetic diseases and disorders
US20080286249A1 (en) *	2006-01-12	2008-11-20	Varney Timothy R	Use of mesenchymal stem cells for treating genetic diseases and disorders
US8871198B2 (en) *	2006-03-29	2014-10-28	Stemnion, Inc.	Methods related to wound healing
US9944900B2 (en) *	2006-01-18	2018-04-17	Hemacell Perfusion	Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
GB0600972D0 (en) *	2006-01-18	2006-03-01	Univ Leeds	Enrichment of cells
US7875451B2 (en) *	2006-01-19	2011-01-25	The University Of Washington	Formulation to improve survival of transplanted cells
CA3124132A1 (en)	2006-01-23	2007-08-02	Abt Holding Company	Mapc therapeutics without adjunctive immunosuppressive treatment
EP1978977A4 (en) *	2006-01-24	2010-03-17	Christopher J Centeno	METHOD AND SYSTEM FOR ISOLATION AND TRANSPLANTATION OF MESENCHYMAL STEM CELLS FOR USE IN CLINICAL MEDIA
FR2896511B1 (fr) *	2006-01-26	2012-10-26	Centre Nat Rech Scient	Procede de culture de cellules issues du tissu adipeux et leurs applications.
WO2007092622A2 (en)	2006-02-09	2007-08-16	Biomimetic Therapeutics, Inc.	Compositions and methods for treating bone
CA2644508A1 (en) *	2006-03-01	2007-09-07	The Regenerative Medicine Institute	Compostions and populations of cells obtained from the umbilical cord and methods of producing the same
WO2007099337A1 (en) *	2006-03-01	2007-09-07	Cartela R&D Ab	Expansion and differentiation of mesenchymal stem cells
KR101490449B1 (ko) *	2006-03-23	2015-02-05	플루리스템 리미티드	세포 증식 방법 및 세포의 용도 및 치료를 위해 그 세포에 의해 제조되는 조절된 배지
US20110171182A1 (en) *	2006-03-23	2011-07-14	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
CA2646491A1 (en) *	2006-04-17	2007-10-25	Bioe, Inc.	Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
WO2007124023A2 (en) *	2006-04-21	2007-11-01	Wake Forest University Health Sciences	Ink-jet printing of tissues
US9456979B2 (en) *	2006-04-27	2016-10-04	Sri International	Adminstration of intact mammalian cells to the brain by the intranasal route
US8741643B2 (en) *	2006-04-28	2014-06-03	Lifescan, Inc.	Differentiation of pluripotent stem cells to definitive endoderm lineage
CA2649874C (en)	2006-05-05	2015-01-27	John E. Davies	Immune privileged and modulatory progenitor cells
CA2909053C (en)	2006-05-11	2021-02-09	Cord Blood Science Inc.	Methods for collecting and using placenta cord blood stem cells
WO2007146105A2 (en) *	2006-06-05	2007-12-21	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
US20080050814A1 (en) *	2006-06-05	2008-02-28	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
KR20090031895A (ko) *	2006-06-09	2009-03-30	안트로제네시스 코포레이션	태반 니치 및 줄기 세포 배양을 위한 이의 용도
WO2007145889A1 (en) *	2006-06-14	2007-12-21	Stemnion, Inc.	Methods of treating spinal cord injury and minimizing scarring
US8475788B2 (en)	2006-06-14	2013-07-02	Stemnion, Inc.	Methods of treating spinal cord injury and minimizing scarring
US20070292401A1 (en) *	2006-06-20	2007-12-20	Harmon Alexander M	Soft tissue repair and regeneration using stem cell products
KR20090038439A (ko) *	2006-06-28	2009-04-20	더 유니버시티 오브 캔사스	탯줄 기질로부터 간세포 리니지 세포로의 줄기 세포 분화
WO2008005427A2 (en)	2006-06-30	2008-01-10	Biomimetic Therapeutics, Inc.	Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
US9161967B2 (en)	2006-06-30	2015-10-20	Biomimetic Therapeutics, Llc	Compositions and methods for treating the vertebral column
AU2006346492A1 (en)	2006-07-24	2008-01-31	International Stem Cell Corporation	Synthetic cornea from retinal stem cells
US7993918B2 (en) *	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
US7892447B2 (en) *	2006-08-11	2011-02-22	Aqua Resources Corporation	Nanoplatelet metal hydroxides and methods of preparing same
US8822030B2 (en)	2006-08-11	2014-09-02	Aqua Resources Corporation	Nanoplatelet metal hydroxides and methods of preparing same
US7671014B2 (en) *	2006-08-14	2010-03-02	Warsaw Orthopedic, Inc.	Flowable carrier matrix and methods for delivering to a patient
US8372437B2 (en)	2006-08-17	2013-02-12	Mimedx Group, Inc.	Placental tissue grafts
JP5656183B2 (ja) *	2006-08-22	2015-01-21	国立大学法人東京医科歯科大学	滑膜由来間葉幹細胞（ＭＳＣｓ）の軟骨・半月板再生への応用
US20080082170A1 (en) *	2006-09-29	2008-04-03	Peterman Marc M	Apparatus and methods for surgical repair
US20080078412A1 (en) *	2006-10-03	2008-04-03	Restore Medical, Inc.	Tongue implant
US20080078411A1 (en) *	2006-10-03	2008-04-03	Restore Medical, Inc.	Tongue implant for sleep apnea
AU2007308168B2 (en)	2006-10-12	2013-09-26	Ethicon, Inc.	Kidney-derived cells and methods of use in tissue repair and regeneration
EP1913869A3 (en) *	2006-10-19	2008-12-10	Esaote S.p.A.	Diagnostic imaging method and apparatus for the anatomical region of the pelvic floor
JP2010507392A (ja)	2006-10-23	2010-03-11	アントフロゲネシスコーポレーション	胎盤細胞集団で骨欠損を治療するための方法及び組成物
CA2668189C (en) *	2006-11-03	2016-01-26	Biomimetic Therapeutics, Inc.	Compositions and methods for arthrodetic procedures comprising a solution of platelet derived growth factor (pdgf) incorporated in a biocompatible matrix
AU2007319820B2 (en) *	2006-11-13	2013-09-05	Ethicon, Incorporated	In vitro expansion of postpartum-derived cells using microcarriers
US20080132803A1 (en) *	2006-11-30	2008-06-05	Hyman Friedlander	Method and system for doing business by mining the placental-chord complex
WO2008073331A2 (en) *	2006-12-07	2008-06-19	Teva Pharmaceutical Industries Ltd.	Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
WO2008082525A1 (en) *	2006-12-19	2008-07-10	National Stem Cell Inc	Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
US20100303770A1 (en) *	2006-12-28	2010-12-02	John Maslowski	Methods for culturing dermal cells for treatment of skin injuries such as burns
US7980000B2 (en) *	2006-12-29	2011-07-19	Applied Materials, Inc.	Vapor dryer having hydrophilic end effector
US8221741B2 (en)	2007-01-17	2012-07-17	Marshall Vivienne S	Methods for modulating inflammatory and/or immune responses
EP2129775A1 (en)	2007-02-12	2009-12-09	Anthrogenesis Corporation	Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
KR20150039214A (ko)	2007-02-12	2015-04-09	안트로제네시스 코포레이션	태반 줄기세포를 이용한 염증 질환의 치료
EP2125000A2 (en) *	2007-02-20	2009-12-02	Biomimetic Therapeutics, Inc.	Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw using pdgf and a bone matrix
AR065584A1 (es) *	2007-03-01	2009-06-17	Cryo Cell Internat Inc	Obtencion aislamiento y crioconservacion de celulas endometriales / menstruales
US8673547B2 (en) *	2007-03-08	2014-03-18	Hemacell Perfusion, Inc.	Method for isolation of afterbirth derived cells
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
CN105861443A (zh) *	2007-04-07	2016-08-17	怀特黑德生物医学研究所	体细胞重编程
WO2009008928A2 (en) *	2007-04-13	2009-01-15	Stemnion, Inc.	Methods for treating nervous system injury and disease
CN101668848B (zh)	2007-04-26	2014-10-22	雷蒙特亚特特拉维夫大学有限公司	来自口腔粘膜的多能自体干细胞和使用方法
US20100291042A1 (en) *	2007-05-03	2010-11-18	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8574567B2 (en)	2007-05-03	2013-11-05	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8114668B2 (en) *	2007-05-14	2012-02-14	Cardiac Pacemakers, Inc.	Composition for cold storage of stem cells
CN101842105B (zh)	2007-05-21	2013-06-19	韦克福里斯特大学健康科学院	来自尿的祖细胞及其使用方法
US20100111914A1 (en) *	2007-05-21	2010-05-06	Yuanyuan Zhang	Stem cells from urine and methods for using the same
TWM322542U (en) *	2007-05-23	2007-11-21	Universal Scient Ind Co Ltd	Testing machine
US20090053182A1 (en) *	2007-05-25	2009-02-26	Medistem Laboratories, Inc.	Endometrial stem cells and methods of making and using same
EP2201910B1 (en) *	2007-06-01	2013-04-03	Allergan, Inc.	Biological tissue growth support trough induced tensile stress
US9693486B1 (en) *	2007-06-14	2017-06-27	Switch, Ltd.	Air handling unit with a canopy thereover for use with a data center and method of using the same
CA2688504A1 (en)	2007-06-18	2008-12-24	Children's Hospital & Research Center At Oakland	Method of isolating stem and progenitor cells from placenta
US20090004253A1 (en) *	2007-06-29	2009-01-01	Brown Laura J	Composite device for the repair or regeneration of tissue
US20090004271A1 (en) *	2007-06-29	2009-01-01	Brown Laura J	Morselized foam for wound treatment
US9080145B2 (en) *	2007-07-01	2015-07-14	Lifescan Corporation	Single pluripotent stem cell culture
US9095562B2 (en)	2007-07-05	2015-08-04	Regenerative Sciences, Inc.	Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
DE102007034679A1 (de)	2007-07-25	2009-01-29	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Materialzusammensetzungen, welche aus exokrinem Drüsengewebe erhaltene adulte Stammzellen enthalten, insbesondere zur Verwendung in der Regenerationsmedizin, z.B. zur Wiederherstellung von verletztem oder geschädigtem Myokardgewebe
US9744043B2 (en)	2007-07-16	2017-08-29	Lifenet Health	Crafting of cartilage
US20090029463A1 (en) *	2007-07-25	2009-01-29	Bioe, Inc.	Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes
ES2451441T3 (es)	2007-07-27	2014-03-27	Humacyte, Inc.	Composiciones que comprenden colágeno humano y elastina humana y usos de las mismas
CN101952415B (zh)	2007-07-31	2017-06-27	生命扫描有限公司	人胚胎干细胞的分化
EP2175898A2 (en) *	2007-08-08	2010-04-21	Pervasis Therapeutics, Inc.	Materials and methods for treating skeletal system damage and promoting skeletal system repair and regeneration
US20090062907A1 (en) *	2007-08-31	2009-03-05	Quijano Rodolfo C	Self-expanding valve for the venous system
US20090068153A1 (en) *	2007-09-06	2009-03-12	Vitelli Francesca P	Cell composition for tissue regeneration
WO2009033160A1 (en)	2007-09-07	2009-03-12	Surgical Biologics	Placental tissue grafts and improved methods of preparing and using the same
JP2010539228A (ja) *	2007-09-19	2010-12-16	プルリステムリミテッド	脂肪組織または胎盤組織に由来する接着性細胞および治療におけるその使用
US20090136553A1 (en) *	2007-09-25	2009-05-28	Gerlach Jorg C	Triggerably dissolvable hollow fibers for controlled delivery
KR20200043517A (ko) *	2007-09-26	2020-04-27	안트로제네시스 코포레이션	인간 태반 관류액으로부터의 혈관형성 세포
KR101955140B1 (ko)	2007-09-28	2019-03-06	안트로제네시스 코포레이션	인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
CN102036688B (zh) *	2007-10-05	2014-07-02	伊西康公司	使用人脐带组织来源的细胞进行肾脏组织的修复和再生
WO2009052209A2 (en) *	2007-10-16	2009-04-23	University Of Kansas	Isolation of stem cells and effective control of contamination
US20120219737A1 (en)	2007-10-19	2012-08-30	University Of Medicine And Dentistry Of New Jersey	Production of extracellular matrix, conditioned media and uses thereof
WO2009052459A1 (en) *	2007-10-19	2009-04-23	University Of Medicine And Dentistry Of New Jersey	A method of using an extracellular matrix to enhance cell transplant survival and differentiation
DK2217329T3 (en) *	2007-11-07	2018-04-23	Anthrogenesis Corp	APPLICATION OF NAVLINE BLOOD IN THE TREATMENT OF COMPLIANCES IN CONNECTION WITH PREGNANCY BIRTH
US20110086080A1 (en) *	2007-11-14	2011-04-14	Osteosphere, Llc	Ex-vivo production of human demineralized bone matrix
CA2706560C (en)	2007-11-27	2017-02-28	Lifescan, Inc.	Differentiation of human embryonic stem cells to pancreatic cells
WO2009085969A2 (en) *	2007-12-19	2009-07-09	Regenerative Sciences, Llc	Compositions and methods to promote implantation and engrafment of stem cells
US20090163990A1 (en) *	2007-12-19	2009-06-25	Chunlin Yang	Decellularized omentum matrix and uses thereof
WO2009085216A2 (en)	2007-12-20	2009-07-09	Squicor	Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease
US8236538B2 (en) *	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
UA99167C2 (ru) *	2007-12-27	2012-07-25	Этикон, Инкорпорейтед	Лечение дегенерации межреберных дисков с использованием клеток, полученных из ткани пуповины человека
US20100279413A1 (en) *	2008-01-14	2010-11-04	Zymes, Llc	Applications of ubiquinones and ubiquinols
US8088163B1 (en)	2008-02-06	2012-01-03	Kleiner Jeffrey B	Tools and methods for spinal fusion
CA2715254A1 (en)	2008-02-07	2009-08-13	Biomimetic Therapeutics, Inc.	Compositions and methods for distraction osteogenesis
EP3095470A1 (en) *	2008-02-07	2016-11-23	Shahar Cohen	Compartmental extract compositions for tissue engineering
US20090209456A1 (en) *	2008-02-19	2009-08-20	Iliana Sweis	Compositions and methods for improving facial and body aesthetics
MX2010009251A (es)	2008-02-21	2010-11-25	Centocor Ortho Biotech Inc	Metodos, placas de superficie modificada y composiciones para la fijacion, el cultivo y el desprendimiento celular.
US8318485B2 (en) *	2008-02-25	2012-11-27	Natalie Gavrilova	Stem cell therapy for the treatment of diabetic retinopathy and diabetic optic neuropathy
US20090220995A1 (en)	2008-02-28	2009-09-03	Sachs David H	Multiple administrations of umbilicus derived cells
EP2257176B1 (en) *	2008-03-14	2013-09-18	Regenerative Sciences, LLC	Compositions and methods for cartilage repair
US20090232782A1 (en) *	2008-03-14	2009-09-17	Yu-Show Fu	Method for treating brain ischemic injury through transplantation of human umbilical mesenchymal stem cells
EP2288359B1 (en)	2008-04-21	2019-10-02	Tissue Regeneration Therapeutics Inc.	Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
US8623648B2 (en)	2008-04-24	2014-01-07	Janssen Biotech, Inc.	Treatment of pluripotent cells
US9358320B2 (en)	2008-04-25	2016-06-07	Allosource	Multi-layer tissue patches
US9480549B2 (en)	2008-04-25	2016-11-01	Allosource	Multi-layer tissue patches
US20090275129A1 (en) *	2008-04-30	2009-11-05	Ethicon, Inc.	Tissue engineered blood vessels
US20110143429A1 (en) *	2008-04-30	2011-06-16	Iksoo Chun	Tissue engineered blood vessels
US20090291494A1 (en) *	2008-05-21	2009-11-26	Bioe, Inc.	Differentiation of Multi-Lineage Progenitor Cells to Pancreatic Cells
US20210378834A1 (en)	2008-05-22	2021-12-09	Spinal Surgical Strategies, Inc., A Nevada Corporation D/B/A Kleiner Device Labs	Spinal fusion cage system with inserter
WO2010011407A2 (en) *	2008-05-23	2010-01-28	President And Fellows Of Harvard College	Methods of generating patterned soft substrates and uses thereof
WO2009155069A1 (en) *	2008-05-28	2009-12-23	Allan Mishra	Compositions and methods for treating psychiatric and neurodegenerative disorders
WO2009152384A1 (en) *	2008-06-11	2009-12-17	The Children's Mercy Hospital	Solutions for tissue engineering and methods of use
CA2727681C (en)	2008-06-13	2017-07-25	Whitehead Institute For Biomedical Research	Programming and reprogramming of cells
US8197806B2 (en) *	2008-06-26	2012-06-12	Kci Licensing, Inc	Stimulation of cartilage formation using reduced pressure treatment
JP5294041B2 (ja) *	2008-06-27	2013-09-18	独立行政法人産業技術総合研究所	膵臓疾患又は糖尿病のための膵臓細胞再生移植用キット
JP2011526784A (ja) *	2008-06-30	2011-10-20	セントコア・オーソ・バイオテツク・インコーポレーテツド	多能性幹細胞の分化
AU2009267137A1 (en)	2008-06-30	2010-01-07	Centocor Ortho Biotech Inc.	Differentiation of pluripotent stem cells
US20100028307A1 (en) *	2008-07-31	2010-02-04	O'neil John J	Pluripotent stem cell differentiation
NZ591294A (en) *	2008-08-20	2012-10-26	Anthrogenesis Corp	Treatment of stroke using isolated placental cells
MX339624B (es) *	2008-08-20	2016-06-02	Anthrogenesis Corp	Composiciones mejoradas de celulas y metodos para preparar las mismas.
CA2965883C (en) *	2008-08-22	2020-05-12	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
EP2334783B1 (en)	2008-09-02	2016-06-22	Pluristem Ltd.	Adherent cells from placenta tissue and use thereof in therapy
BRPI0918611B8 (pt)	2008-09-09	2021-06-22	Biomimetic Therapeutics Inc	composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
US20100069827A1 (en) *	2008-09-12	2010-03-18	Barry Neil Silberg	Pre-Surgical Prophylactic Administration of Antibiotics and Therapeutic Agents
US9446227B2 (en)	2008-09-12	2016-09-20	Sonescence, Inc.	Ultrasonic dispersion of compositions in tissue
ES2821436T3 (es)	2008-10-06	2021-04-26	3 D Matrix Ltd	Tapón de tejidos
US20110300203A1 (en) *	2008-10-22	2011-12-08	Trustees Of Columbia University In The City Of New York	Cartilage regeneration without cell transplantation
JP2012507289A (ja) *	2008-10-31	2012-03-29	ヤンセンバイオテツク，インコーポレーテツド	ヒト胚性幹細胞の膵内分泌系への分化
BRPI0921726B8 (pt)	2008-10-31	2021-07-27	Synthes Gmbh	método para preparar uma composição de implante para promover o crescimento ósseo em um mamífero
KR101712085B1 (ko) *	2008-10-31	2017-03-03	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 췌장 내분비 계통으로의 분화
BRPI0921494A2 (pt)	2008-11-03	2018-10-30	Prad Reasearch And Development Ltd	método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
RU2562154C2 (ru)	2008-11-19	2015-09-10	Антродженезис Корпорейшн	Амниотические адгезивные клетки
CA2744227C (en)	2008-11-20	2018-10-02	Centocor Ortho Biotech Inc.	Methods and compositions for cell attachment and cultivation on planar substrates
PL2366021T3 (pl)	2008-11-20	2017-12-29	Janssen Biotech, Inc.	Hodowla pluripotencjalnych komórek macierzystych na mikronośnikach
JP2012509153A (ja) *	2008-11-20	2012-04-19	ライフセルコーポレーション	傍ストーマヘルニアの治療及び予防のための方法
WO2010060031A1 (en) *	2008-11-21	2010-05-27	Anthrogenesis Corporation	Treatment of diseases, disorders or conditions of the lung using placental cells
KR20120006481A (ko)	2008-12-05	2012-01-18	리제너러티브 사이언시즈, 엘엘씨	무혈관 조직의 복구를 촉진하기 위한 방법 및 조성물
WO2010064702A1 (ja) *	2008-12-05	2010-06-10	国立大学法人東京大学	癌の予後を予測するためのバイオマーカー
US8366748B2 (en)	2008-12-05	2013-02-05	Kleiner Jeffrey	Apparatus and method of spinal implant and fusion
US20100168022A1 (en) *	2008-12-11	2010-07-01	Centeno Christopher J	Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
EP2379089B1 (en) *	2008-12-19	2019-04-17	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue following injury
AU2009327382B2 (en) *	2008-12-19	2014-07-17	DePuy Synthes Products, LLC	Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
US20130302283A1 (en)	2012-05-14	2013-11-14	Advanced Technologies And Regenerative Medicine, Llc	hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
CN107028983A (zh) *	2008-12-19	2017-08-11	德普伊新特斯产品有限责任公司	肺部疾病和病症的治疗
US8771677B2 (en) *	2008-12-29	2014-07-08	Vladimir B Serikov	Colony-forming unit cell of human chorion and method to obtain and use thereof
BRPI0918196A2 (pt) *	2008-12-30	2016-03-01	Kci Licensing Inc	sistema para aplicar um tratamento a uma area lesionada em um primeiro osso de dois ossos que formam uma articulação, metodo para aplicação de um tratamento a uma area lesionada no primeiro osso de dois osso que formam uma articulação, metodo de realização de cirurgia no joelho, uso do sistema de entrega de pressão reduzida e bexiga para a aplicação de um tratamento de uma area lesionada no primeiro osso de dois ossos que formam uma articulação
WO2010084943A1 (ja) *	2009-01-23	2010-07-29	国立大学法人東京大学	培養細胞の評価方法
US9247943B1 (en)	2009-02-06	2016-02-02	Kleiner Intellectual Property, Llc	Devices and methods for preparing an intervertebral workspace
WO2010093468A1 (en) *	2009-02-12	2010-08-19	University Of Southern California	Bioadhesive patch for sutureless closure of soft tissue
KR101422690B1 (ko) *	2009-02-27	2014-07-23	(주)차바이오앤디오스텍	배아줄기세포 유래 혈관형성전구세포의 배양 분비물을 포함하는 피부재생용 조성물 및 이의 용도
EP2411504B1 (en) *	2009-03-26	2017-05-10	DePuy Synthes Products, Inc.	Human umbilical cord tissue cells as therapy for alzheimer's disease
CN102439136A (zh) *	2009-03-26	2012-05-02	加州大学校董	产生用于疾病修饰的抑制性rna的间充质干细胞
WO2010118059A1 (en) *	2009-04-06	2010-10-14	Capricor, Inc.	Systems and methods for cardiac tissue repair
CN102482645B (zh) *	2009-05-13	2015-12-09	米迪波斯特股份有限公司	与干细胞活性相关的凝血栓蛋白1、凝血栓蛋白2、白细胞介素17b受体和肝素结合表皮生长因子样生长因子和其应用
CA2762212C (en) *	2009-05-20	2015-12-29	Humacyte, Inc.	Elastin for soft tissue augmentation
WO2010138782A1 (en) *	2009-05-28	2010-12-02	University Of Central Florida Research	In vitro production of oligodendrocytes from human umbilical cord stem cells
US20150335400A1 (en) *	2009-06-17	2015-11-26	The Trustees Of Columbia University In The City Of New York	Tooth scaffolds
US8647617B2 (en)	2009-07-13	2014-02-11	Stemnion, Inc.	Methods for modulating inflammatory and/or immune responses
SG177483A1 (en) *	2009-07-20	2012-02-28	Janssen Biotech Inc	Differentiation of human embryonic stem cells
SG177416A1 (en) *	2009-07-20	2012-02-28	Janssen Biotech Inc	Differentiation of human embryonic stem cells
RU2579278C2 (ru)	2009-07-20	2016-04-10	Янссен Байотек, Инк.	Популяция панкреатических эндокринных клеток-предшественников для снижения концентрации глюкозы в крови и способ дифференцировки панкреатических эндодермальных клеток
ES2360434B1 (es)	2009-07-21	2012-04-12	Universitat Internacional De Catalunya	Celulas madre pluripotenciales obtenidas a partir de la pulpa dental.
CN102625829B (zh) *	2009-07-21	2015-05-06	Abt控股公司	干细胞用于减少白细胞外渗的用途
WO2011022070A2 (en) *	2009-08-20	2011-02-24	The Regents Of The University Of California	Perivascular stem cell composition for bone
US20110054929A1 (en) *	2009-09-01	2011-03-03	Cell Solutions Colorado Llc	Stem Cell Marketplace
US8207651B2 (en)	2009-09-16	2012-06-26	Tyco Healthcare Group Lp	Low energy or minimum disturbance method for measuring frequency response functions of ultrasonic surgical devices in determining optimum operating point
USD723682S1 (en)	2013-05-03	2015-03-03	Spinal Surgical Strategies, Llc	Bone graft delivery tool
US9186193B2 (en)	2009-09-18	2015-11-17	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US8685031B2 (en)	2009-09-18	2014-04-01	Spinal Surgical Strategies, Llc	Bone graft delivery system
US8906028B2 (en)	2009-09-18	2014-12-09	Spinal Surgical Strategies, Llc	Bone graft delivery device and method of using the same
USD750249S1 (en)	2014-10-20	2016-02-23	Spinal Surgical Strategies, Llc	Expandable fusion cage
US10973656B2 (en)	2009-09-18	2021-04-13	Spinal Surgical Strategies, Inc.	Bone graft delivery system and method for using same
US9060877B2 (en)	2009-09-18	2015-06-23	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US20170238984A1 (en)	2009-09-18	2017-08-24	Spinal Surgical Strategies, Llc	Bone graft delivery device with positioning handle
US10245159B1 (en)	2009-09-18	2019-04-02	Spinal Surgical Strategies, Llc	Bone graft delivery system and method for using same
US9173694B2 (en)	2009-09-18	2015-11-03	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US9629729B2 (en)	2009-09-18	2017-04-25	Spinal Surgical Strategies, Llc	Biological delivery system with adaptable fusion cage interface
CN102686722B (zh) *	2009-09-23	2014-11-05	达芬奇生物科技有限责任公司	脐带衬干细胞及其分离和培养方法和材料
EP2488209B1 (en)	2009-10-16	2016-09-28	Rutgers, the State University of New Jersey	Method for treating chronic nerve tissue injury using a cell therapy strategy
PH12012500818A1 (en) *	2009-10-29	2019-11-29	Janssen Biotech Inc	Pluripotent stem cells
KR20120093993A (ko)	2009-10-30	2012-08-23	아벨라 파마슈티칼스, 인코포레이티드	퇴행성 관절염 치료를 위한 디메틸설폭사이드 및 메틸설포닐메탄 제제
US9113950B2 (en)	2009-11-04	2015-08-25	Regenerative Sciences, Llc	Therapeutic delivery device
US20130028978A1 (en) *	2009-11-10	2013-01-31	The Trustees Of Columbia University In The City Of New York	Compositions and methods for wound treatment
US20130129686A1 (en) *	2009-11-19	2013-05-23	Regents Of The University	Reducing Inflammation Using Cell Therapy
CN102712902B (zh)	2009-12-23	2019-01-08	詹森生物科技公司	人胚胎干细胞的分化
KR101773538B1 (ko)	2009-12-23	2017-08-31	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 분화
US9121007B2 (en) *	2010-01-26	2015-09-01	Anthrogenesis Corporatin	Treatment of bone-related cancers using placental stem cells
US8900859B2 (en)	2010-01-26	2014-12-02	Stem Cells Spin S. A.	Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use
WO2011103446A1 (en)	2010-02-18	2011-08-25	Osiris Therapeutics, Inc.	Immunocompatible chorionic membrane products
WO2011103276A2 (en) *	2010-02-19	2011-08-25	Lifecell Corporation	Abdominal wall treatment devices
CN102811622A (zh)	2010-02-22	2012-12-05	生物模拟治疗公司	用于治疗腱病的血小板衍生生长因子组合物和方法
CN107189979B (zh)	2010-03-01	2021-05-04	詹森生物科技公司	纯化衍生自多能干细胞的细胞的方法
KR20240096688A (ko)	2010-04-07	2024-06-26	셀룰래리티 인코포레이티드	태반 줄기 세포를 사용한 혈관신생
US8562973B2 (en)	2010-04-08	2013-10-22	Anthrogenesis Corporation	Treatment of sarcoidosis using placental stem cells
US9845457B2 (en)	2010-04-30	2017-12-19	Cedars-Sinai Medical Center	Maintenance of genomic stability in cultured stem cells
US8529883B2 (en)	2010-05-07	2013-09-10	Fibrocell Technologies, Inc.	Dosage unit formulations of autologous dermal fibroblasts
RU2663339C1 (ru)	2010-05-12	2018-08-03	Янссен Байотек, Инк.	Дифференцирование эмбриональных стволовых клеток человека
US10130736B1 (en)	2010-05-14	2018-11-20	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en)	2010-05-14	2016-05-31	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en)	2010-05-14	2014-11-11	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2011153236A1 (en) *	2010-06-03	2011-12-08	The Board Of Trustees Of The Leland Stanford Junior University	Purified compositions of cardiovascular progenitor cells
ES2879246T3 (es)	2010-07-02	2021-11-22	Univ North Carolina Chapel Hill	Andamios de biomatriz
ES2963295T3 (es)	2010-07-12	2024-03-26	Univ Southern California	Sustrato biocompatible para facilitar las interconexiones entre células madre y tejidos diana y métodos para implantarlo
CA2804750C (en)	2010-07-13	2022-05-10	Anthrogenesis Corporation	Methods of generating natural killer cells
US8825388B2 (en)	2010-07-13	2014-09-02	Qualcomm Incorporated	Indoor likelihood heatmap
SG187667A1 (en) *	2010-08-03	2013-03-28	Agency Science Tech & Res	Microfabricated scaffold structures
JP2012031127A (ja) *	2010-08-03	2012-02-16	Nagoya Univ	臍帯由来間葉系幹細胞を含む組成物
IL207586A0 (en)	2010-08-12	2010-12-30	Omrix Biopharmaceuticals Ltd	A fibrin based therapeutic preparation and use thereof
WO2012021885A1 (en) *	2010-08-13	2012-02-16	The Trustees Of Columbia University In The City Of New York	Three-dimensional tissue engineering devices and uses thereof
EP2853589B1 (en)	2010-08-31	2017-12-27	Janssen Biotech, Inc.	Differentiation of human embryonic stem cells
WO2012030540A2 (en)	2010-08-31	2012-03-08	Janssen Biotech, Inc.	Differentiation of pluripotent stem cells
US20120052049A1 (en) *	2010-08-31	2012-03-01	Renovocyte, LLC	Systemic, Allogenic Stem Cell Therapies For Treatment of Diseases in Animals
PH12013500367A1 (en)	2010-08-31	2013-04-01	Janssen Biotech Inc	Differentiation of human embryonic stem cells
EP2625263B1 (en)	2010-10-08	2020-03-11	Terumo BCT, Inc.	Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US8546338B2 (en)	2010-12-08	2013-10-01	Johnson & Johnson Consumer Companies, Inc.	Self-assembling hydrogels based on dicephalic peptide amphiphiles
US8574899B2 (en)	2010-12-22	2013-11-05	Vladimir B Serikov	Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
US8969315B2 (en)	2010-12-31	2015-03-03	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory RNA molecules
JP5388233B2 (ja) *	2011-01-19	2014-01-15	富士ソフト株式会社	再生軟骨の軟骨特性を評価する方法
US12093036B2 (en)	2011-01-21	2024-09-17	Teladoc Health, Inc.	Telerobotic system with a dual application screen presentation
CN102614546B (zh) *	2011-01-26	2014-10-15	香港中文大学	用于组织修复和生物人造组织工程的细胞片及其制备方法
EP2686419B1 (en)	2011-03-18	2016-11-16	MicroVascular Tissues, Inc.	Allogeneic microvascular tissue for soft tissue treatments
KR101903339B1 (ko)	2011-03-22	2018-10-01	플루리스템 리미티드	방사선 또는 화학적 손상을 치료하는 방법
WO2012149486A1 (en)	2011-04-28	2012-11-01	Tissuetech, Inc.	Methods of modulating bone remodeling
WO2012148397A1 (en)	2011-04-28	2012-11-01	Aquero Company, Llc	Lysine-based polymer coagulants for use in clarification of process waters
US8877489B2 (en)	2011-12-05	2014-11-04	California Institute Of Technology	Ultrathin parylene-C semipermeable membranes for biomedical applications
US10478206B2 (en)	2011-04-29	2019-11-19	University Of Southern California	Instruments and methods for the implantation of cell-seeded substrates
US8834928B1 (en)	2011-05-16	2014-09-16	Musculoskeletal Transplant Foundation	Tissue-derived tissugenic implants, and methods of fabricating and using same
EP3851131A1 (en)	2011-05-31	2021-07-21	LifeCell Corporation	Adipose tissue matrices
CA2837871C (en)	2011-06-01	2021-12-07	Anthrogenesis Corporation	Treatment of pain using placental stem cells
CA2837878A1 (en)	2011-06-10	2012-12-13	Tissuetech, Inc.	Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
WO2012177927A1 (en)	2011-06-21	2012-12-27	Mayo Foundation For Medical Education And Research	Transgenic animals capable of being induced to delete senescent cells
US20130071360A1 (en)	2011-06-29	2013-03-21	Biorestorative Therapies, Inc.	Brown Fat Cell Compositions and Methods
US20130005829A1 (en)	2011-06-30	2013-01-03	Advanced Technologies And Regenerative Medicine, Llc.	Segmented, epsilon-Caprolactone-Rich, Poly(epsilon-Caprolactone-co-p-Dioxanone) Copolymers for Medical Applications and Devices Therefrom
US10865383B2 (en)	2011-07-12	2020-12-15	Lineage Cell Therapeutics, Inc.	Methods and formulations for orthopedic cell therapy
MX362098B (es)	2011-08-10	2019-01-04	Depuy Synthes Products Llc	El uso de células derivadas de tejido del cordón umbilical y kits que contienen las mismas para el tratamiento de enfermedad vascular periférica.
WO2013055476A1 (en)	2011-09-09	2013-04-18	Anthrogenesis Corporation	Treatment of amyotrophic lateral sclerosis using placental stem cells
US9248013B2 (en)	2011-12-05	2016-02-02	California Institute Of Technology	3-Dimensional parylene scaffold cage
CN104125836A (zh)	2011-12-13	2014-10-29	巴克老龄化研究所	改善医疗治疗的方法
US9162011B2 (en)	2011-12-19	2015-10-20	Allosource	Flowable matrix compositions and methods
WO2013096249A1 (en)	2011-12-20	2013-06-27	Lifecell Corporation	Sheet tissue products
US20130157365A1 (en)	2011-12-20	2013-06-20	Advanced Technologies And Regenerative Medicine, Llc	Induced pluripotent stem cells from human umbilical cord tissue-derived cells
ES2860464T3 (es)	2011-12-20	2021-10-05	Lifecell Corp	Productos de tejido fluidizable
SG11201403473QA (en)	2011-12-22	2014-10-30	Janssen Biotech Inc	Differentiation of human embryonic stem cells into single hormonal insulin positive cells
CA2869681A1 (en)	2011-12-23	2013-06-27	Advanced Technologies And Regenerative Medicine, Llc	Detection of human umbilical cord tissue-derived cells
HUE056817T2 (hu)	2011-12-30	2022-03-28	Amit Patel	Eljárások és készítmények allogén sejt klinikai származtatására és terápiás alkalmazások
AU2013212592B2 (en)	2012-01-24	2016-06-30	Lifecell Corporation	Elongated tissue matrices
US9575054B2 (en) *	2012-02-23	2017-02-21	Anthrogenesis Corporation	Identification of antitumor compounds using placenta
US8940294B2 (en)	2012-03-02	2015-01-27	Tissuetech, Inc.	Methods of isolating and culturing stem cells
KR20140131999A (ko)	2012-03-07	2014-11-14	얀센 바이오테크 인코포레이티드	만능 줄기 세포의 증폭 및 유지를 위한 한정 배지
US20150064137A1 (en)	2012-04-17	2015-03-05	Kythera Biopharmaceuticals, Inc.	Use of engineered viruses to specifically kill senescent cells
US9999637B2 (en)	2012-04-24	2018-06-19	Lifecell Corporation	Functionalized tissue matrices
EP2861238A4 (en)	2012-06-05	2016-03-16	Capricor Inc	OPTIMIZED METHODS FOR GENERATING CARDIAC STEM CELLS FROM CARDIAC TISSUE AND THEIR USE IN CARDIAC THERAPY
ES2897649T3 (es)	2012-06-08	2022-03-02	Janssen Biotech Inc	Diferenciación de células madre embrionarias humanas en células endocrinas pancreáticas
ES2706065T3 (es)	2012-07-06	2019-03-27	3 D Matrix Ltd	Proceso de llenado-acabado para soluciones de péptidos
EP2870173B1 (en)	2012-07-09	2018-10-17	Roche Diagniostics GmbH	Recombinantly produced neutral protease originating from paenibacillus polymyxa
BR112015000547B1 (pt)	2012-07-13	2020-11-10	Lifecell Corporation	método para tratar tecido
US8960674B2 (en)	2012-07-27	2015-02-24	Bally Gaming, Inc.	Batch card shuffling apparatuses including multi-card storage compartments, and related methods
US9828603B2 (en)	2012-08-13	2017-11-28	Cedars Sinai Medical Center	Exosomes and micro-ribonucleic acids for tissue regeneration
US9901080B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9901081B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse for determining the role of senescent cells in cancer
US9872937B2 (en)	2012-09-19	2018-01-23	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
EP3476410B1 (en)	2012-09-19	2021-08-18	MicroVascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
US10596202B2 (en)	2012-09-19	2020-03-24	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
US11819522B2 (en)	2012-09-19	2023-11-21	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
BR112015006393A2 (pt)	2012-09-26	2017-07-04	Lifecell Corp	método para produzir um produto de tecido, produto de tecido produzido por um processo, e método de tratamento
KR101728808B1 (ko) *	2012-09-28	2017-04-20	한국생명공학연구원	아세카이니드 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
ITTO20120859A1 (it) *	2012-10-02	2014-04-03	Univ Degli Studi Torino	Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari
WO2014066649A1 (en) *	2012-10-26	2014-05-01	The Regents Of The University Of California	A strategy for engineering various 3d tissues, organoids and vasculature
WO2014089124A1 (en)	2012-12-03	2014-06-12	Cenexys, Inc.	Immunogenic compositions for inducing an immune response for elimination of senescent cells
US20140170748A1 (en)	2012-12-14	2014-06-19	DePuy Synthes Products, LLC	Nutrient Enriched Media for hUTC Growth
DK2938723T3 (da)	2012-12-31	2023-02-20	Janssen Biotech Inc	Differentiering af humane embryonale stamceller til pancreatiske endokrine celler under anvendelse af hb9-regulatorer
ES2837763T3 (es)	2012-12-31	2021-07-01	Janssen Biotech Inc	Cultivo de células madre embrionarias humanas en la interconexión aire-líquido para la diferenciación en células endocrinas pancreáticas
US10370644B2 (en)	2012-12-31	2019-08-06	Janssen Biotech, Inc.	Method for making human pluripotent suspension cultures and cells derived therefrom
HK1217727A1 (zh)	2012-12-31	2017-01-20	Janssen Biotech, Inc.	用於分化成胰腺內分泌細胞的人多能細胞的懸浮和群集
EP2756754B1 (de)	2013-01-17	2017-01-04	Vita 34 Ag	Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
US20140212390A1 (en) *	2013-01-30	2014-07-31	NuTech Medical, Inc.	Placental Membrane Preparation and Methods of Making and Using Same
HK1218515A1 (zh)	2013-02-05	2017-02-24	人类起源公司	来自胎盘的自然杀伤细胞
US9867939B2 (en)	2013-03-12	2018-01-16	Allergan, Inc.	Adipose tissue combinations, devices, and uses thereof
CA2899246C (en)	2013-03-13	2022-12-06	Allosource	Fascia fibrous compositions and methods for their use and manufacture
EP3882336A1 (en) *	2013-03-14	2021-09-22	Celularity Inc.	Enhanced placental stem cells and uses thereof
CA2899713C (en)	2013-03-15	2022-07-19	Allosource	Cell repopulated collagen matrix for soft tissue repair and regeneration
RU2539750C2 (ru) *	2013-04-09	2015-01-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)	Способ оценки иммуносупрессивных свойств мезенхимальных стромальных клеток человека
US20140350516A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Mechanical syringe accessory
US11229789B2 (en)	2013-05-30	2022-01-25	Neurostim Oab, Inc.	Neuro activator with controller
KR102390107B1 (ko)	2013-05-30	2022-04-25	그라함 에이치. 크리시	국부 신경 자극
US10058572B2 (en) *	2013-08-15	2018-08-28	The Regents Of The University Of California	Placenta-derived multipotent stem cells
US9248384B2 (en)	2013-10-02	2016-02-02	Allergan, Inc.	Fat processing system
WO2015073918A1 (en)	2013-11-16	2015-05-21	Terumo Bct, Inc.	Expanding cells in a bioreactor
CA2932271C (en)	2013-12-06	2024-02-06	Allosource	Methods of drying sheets of tissue
WO2015095380A1 (en) *	2013-12-17	2015-06-25	Kassab Ghassan S	Devices, systems and methods for tissue engineering of luminal grafts
US20190269675A1 (en)	2014-01-28	2019-09-05	Buck Institute for Research and Aging	Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents
US10328058B2 (en)	2014-01-28	2019-06-25	Mayo Foundation For Medical Education And Research	Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
US20170216286A1 (en)	2014-01-28	2017-08-03	Mayo Foundation For Medical Education And Research	Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid
CN112274641A (zh)	2014-01-28	2021-01-29	巴克老龄化研究所	用于杀死衰老细胞和用于治疗衰老相关疾病和病症的方法和组合物
WO2016179043A1 (en) *	2015-05-01	2016-11-10	Dermtech, Inc.	Non-invasive skin collection system
CN106687078B (zh)	2014-02-12	2019-10-25	轨道生物医学有限公司	用于治疗剂的脉络膜上施用的方法和设备
CN106456811B (zh)	2014-03-10	2021-04-02	三维矩阵有限责任公司	肽组合物的灭菌和过滤
CA2939696C (en)	2014-03-10	2023-01-10	3-D Matrix, Ltd.	Self-assembling peptide compositions
WO2015148704A1 (en)	2014-03-25	2015-10-01	Terumo Bct, Inc.	Passive replacement of media
EP3139935A4 (en) *	2014-05-07	2017-11-15	Osiris Therapeutics, Inc.	Therapeutic placental compositions, methods of making and methods of use
WO2015170347A2 (en)	2014-05-09	2015-11-12	Reelabs Private Limited	Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders
US10029048B2 (en)	2014-05-13	2018-07-24	Allergan, Inc.	High force injection devices
CN106414720A (zh)	2014-05-16	2017-02-15	詹森生物科技公司	小分子增强胰腺内分泌细胞中的mafa表达的用途
TW201603818A (zh)	2014-06-03	2016-02-01	組織科技股份有限公司	組成物及方法
US9949874B2 (en)	2014-06-06	2018-04-24	Janssen Biotech, Inc.	Therapeutic agent delivery device with convergent lumen
US9925088B2 (en)	2014-06-06	2018-03-27	Janssen Biotech, Inc.	Sub-retinal tangential needle catheter guide and introducer
US20160000550A1 (en) *	2014-07-05	2016-01-07	Deborah Nagle	Methods for treating diseases of the colon
EP3168297B1 (en) *	2014-07-11	2020-09-16	Metcela Inc.	Cardiac cell culture material
US10322028B2 (en)	2014-09-11	2019-06-18	Orbit Biomedical Limited	Method and apparatus for sensing position between layers of an eye
US10219936B2 (en)	2014-09-11	2019-03-05	Orbit Biomedical Limited	Therapeutic agent delivery device with advanceable cannula and needle
US10064752B2 (en)	2014-09-11	2018-09-04	Orbit Biomedical Limited	Motorized suprachoroidal injection of therapeutic agent
US10258502B2 (en)	2014-09-18	2019-04-16	Orbit Biomedical Limited	Therapeutic agent delivery device
EP3194571A4 (en)	2014-09-18	2018-04-18	North Carolina State University	Mammalian lung spheroids and lung spheroid cells and uses thereof
US9504905B2 (en)	2014-09-19	2016-11-29	Bally Gaming, Inc.	Card shuffling device and calibration method
KR101613478B1 (ko) *	2014-09-22	2016-04-19	(주)안트로젠	중간엽줄기세포-하이드로겔을 함유하는 조성물 및 이의 제조방법
CN106715676A (zh)	2014-09-26	2017-05-24	泰尔茂比司特公司	按计划供养
CA2962444C (en)	2014-10-03	2023-09-05	Cedars-Sinai Medical Center	Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
EP3206670A4 (en)	2014-10-14	2018-06-20	Samuel Lynch	Compositions for treating wounds
US20180280447A1 (en) *	2014-10-29	2018-10-04	Sungkwang Medical Foundation	Placenta-derived cells excreting c3 or c1r complement and composition containing same
DK3212247T3 (da) *	2014-10-31	2021-06-28	The Administrators Of The Tulane Educational Fund	Kirurgiske implantater til erstatning af brystvorte og areola eller beskadiget epidermis
RU2750695C2 (ru)	2014-11-07	2021-07-01	Экзостемтех Ко., Лтд.	Композиция, включающая экзосому, полученную из стволовых клеток, для индукции адипогенной дифференцировки, регенерации жировой ткани, отбеливания кожи или коррекции морщин
CN107206028A (zh) *	2014-12-05	2017-09-26	詹森生物科技公司	使用祖细胞治疗眼部病症
CN106471371B (zh) *	2014-12-05	2018-05-04	宣捷生物科技股份有限公司	区别间充质干细胞的方法
US20170080033A1 (en) *	2014-12-16	2017-03-23	Janssen Biotech, Inc.	Treatment of retinal degeneration using progenitor cells
JP2018500325A (ja) *	2014-12-16	2018-01-11	ヤンセンバイオテツク，インコーポレーテツド	前駆細胞を用いた網膜変性の治療法
SG11201704961VA (en)	2014-12-19	2017-07-28	Janssen Biotech Inc	Suspension culturing of pluripotent stem cells
WO2016111899A1 (en)	2015-01-05	2016-07-14	Petrucci Gary M	Methods and materials for treating lung disorders
WO2016126122A2 (ko) *	2015-02-04	2016-08-11	한양대학교 에리카산학협력단	연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
US11077301B2 (en)	2015-02-21	2021-08-03	NeurostimOAB, Inc.	Topical nerve stimulator and sensor for bladder control
US20160243288A1 (en)	2015-02-23	2016-08-25	Tissuetech, Inc.	Apparatuses and methods for treating ophthalmic diseases and disorders
JP6885870B2 (ja)	2015-03-04	2021-06-16	メゾブラスト・インターナショナル・エスアーエールエル	間葉系幹細胞の細胞培養法
AU2016229013B2 (en)	2015-03-10	2020-05-21	Allergan Sales, Llc	Multiple needle injector
CN107530379A (zh)	2015-03-11	2018-01-02	佩特尼资源有限公司	用于治疗肥胖症和2型糖尿病(t2d)的胰腺内分泌祖细胞疗法
WO2016160918A1 (en) *	2015-03-31	2016-10-06	The University Of North Carolina At Chapel Hill	Delivery vehicles for stem cells and uses thereof
US10286009B2 (en) *	2015-05-16	2019-05-14	Asterias Biotherapeutics, Inc.	Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury
CA2984443A1 (en)	2015-05-20	2016-11-24	Tissuetech, Inc.	Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
US10531957B2 (en)	2015-05-21	2020-01-14	Musculoskeletal Transplant Foundation	Modified demineralized cortical bone fibers
US10335435B2 (en)	2015-05-22	2019-07-02	Marco Merida	Method for endoscopically delivering stem cells to the brain using an intranasal, injectable approach
WO2017004592A1 (en)	2015-07-02	2017-01-05	Terumo Bct, Inc.	Cell growth with mechanical stimuli
US10384207B2 (en)	2015-07-21	2019-08-20	Neuro Probe Incorporated	Assay apparatus and methods
WO2017019822A1 (en) *	2015-07-29	2017-02-02	Medivation Technologies, Inc.	Pellet composition containing repair cells
WO2017019832A1 (en)	2015-07-29	2017-02-02	Medivation Technologies, Inc.	Methods and compositions using repair cells and cationic dyes
EP3342858B1 (en)	2015-08-28	2023-10-04	Rohto Pharmaceutical Co., Ltd.	Ror1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ror1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating diseases by using ror1-positive mesenchymal stem cells
USD797290S1 (en)	2015-10-19	2017-09-12	Spinal Surgical Strategies, Llc	Bone graft delivery tool
EP3377225A4 (en)	2015-11-18	2019-07-03	President and Fellows of Harvard College	CASSETTE-BASED SYSTEM FOR LONG-TERM OVERLOOKING OF CENTLES
KR20180088713A (ko) *	2015-12-04	2018-08-06	얀센 바이오테크 인코포레이티드	전구 세포를 사용한 망막 변성의 치료
KR20170076484A (ko) *	2015-12-24	2017-07-04	삼성전자주식회사	프로토카데린의 과발현을 이용한 노화 세포를 분리하는 방법
WO2017120092A1 (en)	2016-01-06	2017-07-13	3-D Matrix, Ltd.	Combination compositions
EP3402543B1 (en)	2016-01-11	2021-09-08	Cedars-Sinai Medical Center	Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
SG11201805533QA (en)	2016-01-14	2018-07-30	Depuy Synthes Products Inc	Composition and methods for cryopreservation of hutc
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
US10993969B2 (en)	2016-02-05	2021-05-04	Gary M. Petrucci	Methods and materials for treating nerve injuries and neurological disorders
US11458224B2 (en)	2016-03-04	2022-10-04	University of Pittsburgh—of the Commonwealth System of Higher Education	Ovarian-derived hydrogels for biomedical and biotechnology applications
US10478553B2 (en)	2016-03-09	2019-11-19	Orbit Biomedical Limited	Apparatus for subretinal administration of therapeutic agent via a curved needle
GB201604304D0 (en)	2016-03-14	2016-04-27	Tigenix S A U	Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP3223181B1 (en) *	2016-03-24	2019-12-18	Sofradim Production	System and method of generating a model and simulating an effect on a surgical repair site
CN116121189A (zh)	2016-03-30	2023-05-16	阿斯特利亚斯生物治疗股份公司	少突胶质细胞祖细胞组合物
KR102232054B1 (ko)	2016-04-08	2021-03-26	알레간 인코포레이티드	흡인 및 주입 디바이스
MA45479A (fr)	2016-04-14	2019-02-20	Janssen Biotech Inc	Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
CN109104869B (zh)	2016-04-27	2022-07-01	日本乐敦制药株式会社	表达细胞表面标记物的间充质干细胞、包含该间充质干细胞的药物组合物及其制备方法
JP7034949B2 (ja)	2016-05-25	2022-03-14	テルモビーシーティー、インコーポレーテッド	細胞の増殖
WO2017210652A1 (en)	2016-06-03	2017-12-07	Cedars-Sinai Medical Center	Cdc-derived exosomes for treatment of ventricular tachyarrythmias
US11685883B2 (en)	2016-06-07	2023-06-27	Terumo Bct, Inc.	Methods and systems for coating a cell growth surface
US11104874B2 (en)	2016-06-07	2021-08-31	Terumo Bct, Inc.	Coating a bioreactor
US10806629B2 (en)	2016-06-17	2020-10-20	Gyroscope Therapeutics Limited	Injection device for subretinal delivery of therapeutic agent
US11000410B2 (en)	2016-06-17	2021-05-11	Gyroscope Therapeutics Limited	Guide apparatus for tangential entry into suprachoroidal space
US10646374B2 (en)	2016-06-17	2020-05-12	Orbit Biomedical Limited	Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent
MA45502A (fr)	2016-06-21	2019-04-24	Janssen Biotech Inc	Génération de cellules bêta fonctionnelles dérivées de cellules souches pluripotentes humaines ayant une respiration mitochondriale glucose-dépendante et une réponse en sécrétion d'insuline en deux phases
CA3029997A1 (en) *	2016-07-05	2018-01-11	Janssen Biotech, Inc.	Treatment of retinal vascular disease using progenitor cells
EP3777907A1 (en)	2016-07-05	2021-02-17	LifeCell Corporation	Tissue matrices incorporating multiple tissue types
EP3500193A4 (en) *	2016-08-19	2020-04-08	Regentys Corporation	EXTRACELLULAR MATRIX FOR TISSUE RECONSTRUCTION OF MUCOUS TISSUE
ES3042057T3 (en) *	2016-08-26	2025-11-18	Restem Llc	Composition and methods of using umbilical cord lining stem cells
US11541078B2 (en)	2016-09-20	2023-01-03	Cedars-Sinai Medical Center	Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
MX2019005172A (es) *	2016-11-02	2019-09-26	Axogen Corp	Injertos de tejido amniotico y metodos para preparar y usar los mismos.
RU2644306C1 (ru) *	2016-11-22	2018-02-08	Общество с ограниченной ответственностью "ДЖИ-Групп"	Способ восстановления дефектов покровных тканей
WO2018125851A1 (en) *	2016-12-26	2018-07-05	Michael Moeller	Systems and methods to isolate and expand stem cells from urine
US11273072B2 (en)	2017-01-13	2022-03-15	Gyroscope Therapeutics Limited	Suprachoroidal injection device
US10772986B2 (en)	2017-01-26	2020-09-15	Allosource	Fascia fibrous compositions and methods for their use and manufacture
WO2018164228A1 (ja)	2017-03-08	2018-09-13	ロート製薬株式会社	Ｒｏｒ１陽性の間葉系幹細胞を含有する、線維症を伴う疾患の予防又は処置のための医薬組成物、及びその調製方法、並びにｒｏｒ１陽性の間葉系幹細胞を用いる線維症を伴う疾患の予防又は処置方法
US11076984B2 (en)	2017-03-13	2021-08-03	Gyroscope Therapeutics Limited	Method of performing subretinal drainage and agent delivery
US11278597B2 (en)	2017-03-17	2022-03-22	Rutgers, The State University Of New Jersey	Compositions and methods for wound healing
US10767164B2 (en)	2017-03-30	2020-09-08	The Research Foundation For The State University Of New York	Microenvironments for self-assembly of islet organoids from stem cells differentiation
EP3656841A1 (en)	2017-03-31	2020-05-27	Terumo BCT, Inc.	Cell expansion
US12234441B2 (en)	2017-03-31	2025-02-25	Terumo Bct, Inc.	Cell expansion
US11624046B2 (en)	2017-03-31	2023-04-11	Terumo Bct, Inc.	Cell expansion
EP3610000A1 (en)	2017-04-13	2020-02-19	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
WO2018195210A1 (en)	2017-04-19	2018-10-25	Cedars-Sinai Medical Center	Methods and compositions for treating skeletal muscular dystrophy
US10478531B2 (en)	2017-06-22	2019-11-19	Gary M. Petrucci	Methods and materials for treating blood vessels
IL271634B2 (en) *	2017-06-29	2024-09-01	Xintela Ab	Quality assurance of chondrocytes
WO2019018545A1 (en)	2017-07-18	2019-01-24	The Research Foundation For The State University Of New York	BIOMARKERS OF INTRACRANIAL ANEVISM
US10251917B1 (en)	2017-09-19	2019-04-09	Gary M. Petrucci	Methods and materials for treating tumors
AU2018351051A1 (en)	2017-10-18	2020-03-19	Lifecell Corporation	Adipose tissue products and methods of production
US11123375B2 (en)	2017-10-18	2021-09-21	Lifecell Corporation	Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US11246994B2 (en)	2017-10-19	2022-02-15	Lifecell Corporation	Methods for introduction of flowable acellular tissue matrix products into a hand
ES2960617T3 (es)	2017-10-19	2024-03-05	Lifecell Corp	Productos de matriz de tejido acelular fluida y métodos de producción
US11629318B2 (en)	2017-10-20	2023-04-18	President And Fellows Of Harvard College	Methods for producing mature adipocytes and methods of use thereof
US20210038650A1 (en) *	2017-10-23	2021-02-11	Cell Medicine, Inc.	Mesenchymal stem cell therapy of leigh syndrome
US20190134100A1 (en) *	2017-11-03	2019-05-09	Janssen Biotech, Inc.	Method of inhibiting angiogenesis
EP3706856A4 (en)	2017-11-07	2021-08-18	Neurostim Oab, Inc.	NON-INVASIVE NERVOUS ACTIVATOR WITH ADAPTIVE CIRCUIT
WO2019126068A1 (en)	2017-12-20	2019-06-27	Cedars-Sinai Medical Center	Engineered extracellular vesicles for enhanced tissue delivery
US11285177B2 (en)	2018-01-03	2022-03-29	Globus Medical, Inc.	Allografts containing viable cells and methods thereof
CN111565732A (zh)	2018-01-12	2020-08-21	国立大学法人大阪大学	复层扁平上皮细胞的正常分化-成熟促进剂、上皮疾病治疗剂以及复层扁平上皮细胞的正常分化-成熟促进方法
US20190218521A1 (en) *	2018-01-18	2019-07-18	Lorenzo Bracco	Culture medium of viruses for human vaccines have to consist of human cells from placenta and/or from umbilical cord of a fetus of the blood type 0 Rh- and of the mother of the blood type 0 Rh- (both, fetus and mother, must be of the blood type 0 Rh-)
US20200360563A1 (en) *	2018-01-30	2020-11-19	University Of Georgia Research Foundation, Inc.	Methods for Vascular Construction and Products Therefrom
US12146137B2 (en)	2018-02-05	2024-11-19	Cedars-Sinai Medical Center	Methods for therapeutic use of exosomes and Y-RNAS
CN108384752A (zh) *	2018-02-13	2018-08-10	中国人民解放军第四五五医院	成软骨培养基及其在微分裂技术中膝关节软骨分化中的应用
EP3801028A4 (en)	2018-05-30	2022-04-13	Direct Biologics LLC	A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
CN108961233A (zh) *	2018-06-28	2018-12-07	华侨大学	一种聚晶金刚石复合片表面缺陷分类识别方法
EP3853345A4 (en)	2018-09-19	2022-07-13	Lineage Cell Therapeutics, Inc.	Methods for differentiating pluripotent stem cells in dynamic suspension culture
WO2020081869A1 (en)	2018-10-17	2020-04-23	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
US11419898B2 (en)	2018-10-17	2022-08-23	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
KR102910994B1 (ko)	2019-01-23	2026-01-12	아스테리아스 바이오세라퓨틱스, 인크.	인간 만능 줄기 세포로부터의 배측-유래된 희소돌기아교세포 전구 세포
WO2020161748A1 (en)	2019-02-08	2020-08-13	Regrow Biosciences Private Limited	Method for mesenchymal stem cell isolation and osteoblast differentiation
US11759355B1 (en)	2019-02-26	2023-09-19	Gyroscope Therapeutics Limited	Method of delivering leading blebs and agent to subretinal space
KR102169924B1 (ko) *	2019-03-26	2020-10-26	연세대학교 산학협력단	연골세포 분화 유도용 조성물 및 이의 용도
KR102167257B1 (ko) *	2019-05-28	2020-10-19	부산대학교 산학협력단	토마티딘 처리를 통한 줄기세포의 성숙화된 심근세포로의 분화유도 촉진 방법
US11633521B2 (en)	2019-05-30	2023-04-25	Lifecell Corporation	Biologic breast implant
JP2022538419A (ja)	2019-06-26	2022-09-02	ニューロスティムテクノロジーズエルエルシー	適応回路を備えた非侵襲性神経活性化装置
AU2020315475A1 (en)	2019-07-18	2022-02-03	Direct Biologics Llc	Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
JP7757793B2 (ja) *	2019-08-29	2025-10-22	味の素株式会社	間葉系幹細胞を含む生体由来細胞試料から間葉系幹細胞を製造する方法
WO2021050907A1 (en) *	2019-09-13	2021-03-18	The University Of North Carolina At Chapel Hill	Method of making human mouse xenografts
WO2021071875A1 (en) *	2019-10-07	2021-04-15	University Of Utah Research Foundation	Chondrogenic human mesenchymal stem cell (msc) sheets
US11771834B2 (en)	2019-10-11	2023-10-03	Gyroscope Therapeutics Limited	Dose clip assembly for syringe
US12441984B2 (en)	2019-11-08	2025-10-14	Kansas State University Research Foundation	Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells
TWI776276B (zh) *	2019-11-13	2022-09-01	中國醫藥大學	異種組織細胞組合物治療癌症之用途
CA3152451A1 (en)	2019-12-16	2021-06-24	Michael Bernard Druke	Non-invasive nerve activator with boosted charge delivery
CA3182658A1 (en)	2020-05-08	2021-11-11	Gallant Pet, Inc.	Uterine-derived regenerative cell compositions and uses thereof
CN111718410B (zh) *	2020-06-05	2022-10-11	江南大学	一种制备卵黄免疫球蛋白的方法
JP6967308B1 (ja)	2020-06-30	2021-11-17	国立大学法人高知大学	胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN113755432B (zh) *	2020-07-17	2022-06-10	上海我武干细胞科技有限公司	干细胞培养方法
WO2022046954A1 (en) *	2020-08-25	2022-03-03	Celularity Inc.	Appl cells improved placental-derived adherent cells and methods of their use
CN114246985A (zh) *	2020-09-25	2022-03-29	华东理工大学	一种类骨膜组织的仿生构建方法
US12347100B2 (en)	2020-11-19	2025-07-01	Mazor Robotics Ltd.	Systems and methods for generating virtual images
US12171688B2 (en)	2020-12-22	2024-12-24	Genentech, Inc.	Ocular cannula guide
CN116802501A (zh) *	2021-01-12	2023-09-22	雪拉托兹治疗株式会社	具有神经元再生活性的神经元再生促进细胞的筛选方法
JP7785378B2 (ja) *	2021-01-12	2025-12-15	セラトズセラピュティクスインコーポレイテッド	神経再生活性を有する神経再生促進細胞のスクリーニング方法
GB2619893A (en)	2021-03-23	2023-12-20	Terumo Bct Inc	Cell capture and expansion
EP4448026A1 (en) *	2021-12-17	2024-10-23	Solventum Intellectual Properties Company	Wound dressings and methods of making the same
US12435312B2 (en)	2022-02-28	2025-10-07	Brown University	Quantifying cell-derived changes in collagen synthesis, alignment, and mechanics in a 3D connective tissue model
US12209689B2 (en)	2022-02-28	2025-01-28	Terumo Kabushiki Kaisha	Multiple-tube pinch valve assembly
CN115068438B (zh) *	2022-04-28	2023-09-22	浙江大学医学院附属邵逸夫医院	破骨细胞前体同源靶向的细胞膜纳米囊泡制备方法及应用
ES2956802B2 (es) *	2022-05-20	2025-10-02	Bioiberica S A U	Hidrogeles para su uso en ingenieria de tejidos de la piel
CN115044542B (zh) *	2022-06-30	2023-09-26	上海市东方医院（同济大学附属东方医院）	Sj000291942在诱导间充质干细胞成骨分化方面的应用
US20250339584A1 (en) *	2022-07-26	2025-11-06	Osaka University	Composition for cartilage repair and method for manufacturing same
USD1099116S1 (en)	2022-09-01	2025-10-21	Terumo Bct, Inc.	Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
IL319330A (en)	2022-09-06	2025-05-01	Genentech Inc	A device for subretinal administration of a therapeutic agent using a double curved needle
EP4379046A1 (en)	2022-11-30	2024-06-05	Universidade Nova De Lisboa	A 3d cellular model of early diabetic retinopathy
WO2024116114A1 (en)	2022-11-30	2024-06-06	Universidade Nova De Lisboa	A 3d cellular model of early diabetic retinopathy
CN116218769B (zh) *	2023-01-03	2025-09-05	深圳市汉科生物工程有限公司	一种促进软骨细胞生长的方法
AU2024207490A1 (en)	2023-01-13	2025-07-24	Genentech, Inc.	Dose dock for syringe
WO2024172859A1 (en) *	2023-02-17	2024-08-22	Spine Biopharma, Inc.	Peptide formulations
WO2025072590A1 (en)	2023-09-29	2025-04-03	Genentech, Inc.	Ocular cannula guide, applicator, and marking instrument
WO2025080727A1 (en) *	2023-10-10	2025-04-17	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Autologous serum insert for treating an ocular condition
WO2025207699A1 (en)	2024-03-27	2025-10-02	Genentech, Inc.	Torque ring for subretinal injection device
US12502407B2 (en)	2024-04-25	2025-12-23	Direct Biologics, Llc	Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (326)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US229971A (en)		1880-07-13		Ttornets
US2324800A (en) *	1941-08-14	1943-07-20	Pfizer Charles & Co	Purification of riboflavin
US2654735A (en) *	1949-07-29	1953-10-06	Us Vitamin Corp	Process for the production of derivatives of 9-polyhydroxyalkylisoalloxazines and products obtained
US2864848A (en) *	1954-07-19	1958-12-16	Ca Nat Research Council	Method of producing l-alpha-glycerylphosphorylcholine
US2912332A (en) *	1958-02-27	1959-11-10	Swift & Co	Stabilized thiamine composition and method of enriching food products
US3665061A (en)	1969-07-16	1972-05-23	United States Banknote Corp	Process for producing collagen sponges
JPS5651747B2 (pl)	1973-05-31	1981-12-08
CH635748A5 (fr)	1977-08-16	1983-04-29	Cellorgan Laboratoires Sa	Procede d'obtention de cellules placentaires de brebis.
US4216144A (en)	1977-10-20	1980-08-05	Ashmead H H	Soluble iron proteinates
JPS6040439B2 (ja) *	1978-03-29	1985-09-11	大正製薬株式会社	ヒドロコルチゾン誘導体
US4352883A (en)	1979-03-28	1982-10-05	Damon Corporation	Encapsulation of biological material
US4393240A (en)	1981-07-06	1983-07-12	Stille John K	Optically active phosphines
US4544516A (en)	1982-07-28	1985-10-01	Battelle Development Corporation	Collagen orientation
US4465776A (en) *	1982-09-27	1984-08-14	Research Corporation	Monoclonal antibodies to vitamin B6 and immunoassay method
US4657866A (en) *	1982-12-21	1987-04-14	Sudhir Kumar	Serum-free, synthetic, completely chemically defined tissue culture media
US4487865A (en) *	1983-12-15	1984-12-11	Biomatrix, Inc.	Polymeric articles modified with hyaluronate
US5266480A (en)	1986-04-18	1993-11-30	Advanced Tissue Sciences, Inc.	Three-dimensional skin culture system
US5902741A (en)	1986-04-18	1999-05-11	Advanced Tissue Sciences, Inc.	Three-dimensional cartilage cultures
US4963489A (en)	1987-04-14	1990-10-16	Marrow-Tech, Inc.	Three-dimensional cell and tissue culture system
US5863531A (en) *	1986-04-18	1999-01-26	Advanced Tissue Sciences, Inc.	In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US4925667A (en) *	1986-05-27	1990-05-15	Qmax Technology Group, Inc.	Substrate with particulate cosmetic
JPS642643A (en)	1987-06-26	1989-01-06	Bio Material Yunibaasu:Kk	Artificial skin
NZ226750A (en)	1987-10-29	1990-09-26	Amrad Corp Ltd	Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5004681B1 (en)	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5192553A (en)	1987-11-12	1993-03-09	Biocyte Corporation	Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5162405A (en) *	1987-12-24	1992-11-10	Elf Atochem North America, Inc.	Single-functional and mixtures of multi-functional oligomeric performance additive compositions and their uses
GB8803697D0 (en)	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
US4963439A (en)	1988-04-19	1990-10-16	Ube Industries, Ltd.	Continuous fiber-reinforced Al-Co alloy matrix composite
US20030032178A1 (en)	1988-08-04	2003-02-13	Williams Robert Lindsay	In vitro propagation of embryonic stem cells
US5618670A (en) *	1988-08-26	1997-04-08	The United States Of America As Represented By The Department Of Health & Human Services	Detection method for c-raf-1 genes
US4925677A (en)	1988-08-31	1990-05-15	Theratech, Inc.	Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
JPH06104061B2 (ja)	1989-02-10	1994-12-21	花王株式会社	細胞培養支持体材料
US5284766A (en)	1989-02-10	1994-02-08	Kao Corporation	Bed material for cell culture
DE69009237T2 (de) *	1989-02-27	1994-12-01	Takasago Perfumery Co Ltd	Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
FR2646438B1 (fr)	1989-03-20	2007-11-02	Pasteur Institut	Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
US5437994A (en) *	1989-06-15	1995-08-01	Regents Of The University Of Michigan	Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5574205A (en)	1989-07-25	1996-11-12	Cell Genesys	Homologous recombination for universal donor cells and chimeric mammalian hosts
US5840580A (en)	1990-05-01	1998-11-24	Becton Dickinson And Company	Phenotypic characterization of the hematopoietic stem cell
US5145770A (en) *	1990-06-04	1992-09-08	Biosurface Technology, Inc.	Cryopreservation of cultured epithelial sheets
US5612205A (en)	1990-08-29	1997-03-18	Genpharm International, Incorporated	Homologous recombination in mammalian cells
US5336616A (en) *	1990-09-12	1994-08-09	Lifecell Corporation	Method for processing and preserving collagen-based tissues for transplantation
US5342761A (en)	1990-10-01	1994-08-30	Research Development Foundation	Oncofetal gene, gene product and uses therefor
US5506134A (en)	1990-10-22	1996-04-09	Corvas International, Inc.	Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5486359A (en)	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
US5811094A (en) *	1990-11-16	1998-09-22	Osiris Therapeutics, Inc.	Connective tissue regeneration using human mesenchymal stem cell preparations
US5140100A (en) *	1990-12-28	1992-08-18	Cedars-Sinai Medical Center	Protein that inhibits production of human choriogonadotropin
US5286632A (en)	1991-01-09	1994-02-15	Jones Douglas H	Method for in vivo recombination and mutagenesis
NL9100038A (nl) *	1991-01-11	1992-08-03	Stamicarbon	Enzym-gekatalyseerde bereiding van optisch aktieve carbonzuren.
DE69232615T2 (de)	1991-05-02	2003-01-30	Cohen, Irun R.	Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen
US6399369B1 (en)	1991-07-08	2002-06-04	Neurospheres Holdings Ltd.	Multipotent neural stem cell cDNA libraries
WO1993003139A1 (fr)	1991-08-08	1993-02-18	Kao Corporation	Support pour la culture de cellules, production de ce support et production d'un amas de cellules au moyen de ce support
EP0529751A1 (en)	1991-08-09	1993-03-03	W.R. Grace & Co.-Conn.	Cell culture substrate, test material for cell culture and preparations thereof
AU2515992A (en)	1991-08-20	1993-03-16	Genpharm International, Inc.	Gene targeting in animal cells using isogenic dna constructs
AU2694592A (en) *	1991-09-30	1993-05-03	Walser, Mackenzie	Methods for treatment of free-radical-mediated tissue injury
US5308763A (en) *	1991-10-01	1994-05-03	The Johns Hopkins University	Method of making primary culture of olfactory neurons
US5914265A (en) *	1992-04-30	1999-06-22	Baylor College Of Medicine	Keratin K1 expression vectors and methods of use
AU4543193A (en)	1992-06-22	1994-01-24	Henry E. Young	Scar inhibitory factor and use thereof
US5320962A (en) *	1992-07-22	1994-06-14	Duke University	DNA encoding the human A1 adenosine receptor
US5589376A (en) *	1992-07-27	1996-12-31	California Institute Of Technology	Mammalian neural crest stem cells
US5356807A (en) *	1992-09-08	1994-10-18	Cornell Research Foundation	Cultured cell line of adult diploid cells from human brain and meningeal tissue
US20040224409A1 (en)	1992-09-25	2004-11-11	Laurent Pradier	Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
US5677181A (en)	1992-10-29	1997-10-14	The Australian National University	Angiogenesis inhibitory antibodies
US5955343A (en)	1992-12-28	1999-09-21	Massachusetts Institute Of Technology	Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en)	1992-12-28	1997-09-23	Massachusetts Insititute Of Technology	Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5707643A (en)	1993-02-26	1998-01-13	Santen Pharmaceutical Co., Ltd.	Biodegradable scleral plug
US5494899A (en) *	1993-04-07	1996-02-27	Oklahoma Medical Research Foundation	Selective regulation of B lymphocyte precursors by hormones
WO1994025584A1 (en)	1993-04-28	1994-11-10	Johns Hopkins University School Of Medicine	Chronic endothelial cell culture under flow
IL110589A0 (en)	1993-08-10	1994-11-11	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF- beta family
JP3680114B2 (ja)	1993-09-17	2005-08-10	敏一中村	脳神経障害治療剤
US6686198B1 (en)	1993-10-14	2004-02-03	President And Fellows Of Harvard College	Method of inducing and maintaining neuronal cells
US6432711B1 (en)	1993-11-03	2002-08-13	Diacrin, Inc.	Embryonic stem cells capable of differentiating into desired cell lines
US5456835A (en) *	1993-11-08	1995-10-10	Hemasure, Inc.	Device and process for removing free hemoglobin from blood
DE4406073A1 (de) *	1994-02-24	1995-08-31	Univ Ludwigs Albert	Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten
US5698518A (en)	1994-03-30	1997-12-16	Oklahoma Medical Research Foundation	Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
US5466233A (en)	1994-04-25	1995-11-14	Escalon Ophthalmics, Inc.	Tack for intraocular drug delivery and method for inserting and removing same
US6703017B1 (en)	1994-04-28	2004-03-09	Ixion Biotechnology, Inc.	Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US6001647A (en)	1994-04-28	1999-12-14	Ixion Biotechnology, Inc.	In vitro growth of functional islets of Langerhans and in vivo uses thereof
US5834308A (en)	1994-04-28	1998-11-10	University Of Florida Research Foundation, Inc.	In vitro growth of functional islets of Langerhans
WO1995033421A1 (en)	1994-06-06	1995-12-14	Case Western Reserve University	Biomatrix for tissue regeneration
IL114397A0 (en)	1994-07-01	1995-10-31	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF-beta-family
US5935849A (en) *	1994-07-20	1999-08-10	Cytotherapeutics, Inc.	Methods and compositions of growth control for cells encapsulated within bioartificial organs
US6309853B1 (en)	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5660982A (en) *	1994-10-04	1997-08-26	Tryggvason; Karl	Laminin chains: diagnostic uses
US5789147A (en) *	1994-12-05	1998-08-04	New York Blood Center, Inc.	Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5725493A (en)	1994-12-12	1998-03-10	Avery; Robert Logan	Intravitreal medicine delivery
US5684032A (en)	1994-12-13	1997-11-04	Smithkline Beecham Corporation	Compounds
US5843780A (en)	1995-01-20	1998-12-01	Wisconsin Alumni Research Foundation	Primate embryonic stem cells
US5736396A (en)	1995-01-24	1998-04-07	Case Western Reserve University	Lineage-directed induction of human mesenchymal stem cell differentiation
US5906934A (en)	1995-03-14	1999-05-25	Morphogen Pharmaceuticals, Inc.	Mesenchymal stem cells for cartilage repair
US5718922A (en) *	1995-05-31	1998-02-17	Schepens Eye Research Institute, Inc.	Intravitreal microsphere drug delivery and method of preparation
US5869079A (en)	1995-06-02	1999-02-09	Oculex Pharmaceuticals, Inc.	Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5693332C1 (en)	1995-08-11	2001-01-09	Univ California	Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5641750A (en)	1995-11-29	1997-06-24	Amgen Inc.	Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US6200606B1 (en)	1996-01-16	2001-03-13	Depuy Orthopaedics, Inc.	Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5842477A (en)	1996-02-21	1998-12-01	Advanced Tissue Sciences, Inc.	Method for repairing cartilage
AU733382B2 (en)	1996-03-15	2001-05-10	Munin Corporation	Extracellular matrix signalling molecules
US6223188B1 (en) *	1996-04-10	2001-04-24	Sun Microsystems, Inc.	Presentation of link information as an aid to hypermedia navigation
CA2253724A1 (en)	1996-04-26	1997-11-06	Case Western Reserve University	Skin regeneration using mesenchymal stem cells
US6358737B1 (en) *	1996-07-31	2002-03-19	Board Of Regents, The University Of Texas System	Osteocyte cell lines
US6787355B1 (en)	1996-08-26	2004-09-07	Mcgill University	Multipotent neural stem cells from peripheral tissues and uses thereof
US5919702A (en) *	1996-10-23	1999-07-06	Advanced Tissue Science, Inc.	Production of cartilage tissue using cells isolated from Wharton's jelly
US6541028B1 (en)	1997-01-17	2003-04-01	Celadon Science, Llc	Methods for promoting healing of corneal resurfacing wounds
AU6144698A (en)	1997-02-05	1998-08-25	Case Western Reserve University	Stimulatory effects of bfgf and bmp-2 on osteogenic differentiation of mesenchymal stem cells
CA2288690A1 (en)	1997-05-13	1998-11-19	Osiris Therapeutics, Inc.	Osteoarthritis cartilage regeneration using human mesenchymal stem cells
JP2002513383A (ja) *	1997-05-21	2002-05-08	スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ	患者の脳組織でのアスコルビン酸の濃度を増加させる方法
JP4132089B2 (ja)	1997-05-30	2008-08-13	オステオバイオロジックス，インコーポレイテッド	繊維強化多孔性生体分解性移植デバイス
ATE307195T1 (de)	1997-07-14	2005-11-15	Osiris Therapeutics Inc	Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
US5902598A (en)	1997-08-28	1999-05-11	Control Delivery Systems, Inc.	Sustained release drug delivery devices
CN1166773C (zh)	1997-12-02	2004-09-15	泽恩比奥公司	分离的人脂肪组织衍生的基质细胞
US6059968A (en)	1998-01-20	2000-05-09	Baxter International Inc.	Systems for processing and storing placenta/umbilical cord blood
US6291240B1 (en)	1998-01-29	2001-09-18	Advanced Tissue Sciences, Inc.	Cells or tissues with increased protein factors and methods of making and using same
PT1062321E (pt)	1998-03-13	2005-05-31	Osiris Therapeutics Inc	Utilizacoes para celulas estaminais mesenquimais humanas nao autologas
EP1076563B1 (en)	1998-03-16	2005-05-11	Cytovia, Inc.	Dipeptide caspase inhibitors and the use thereof
US6179872B1 (en)	1998-03-17	2001-01-30	Tissue Engineering	Biopolymer matt for use in tissue repair and reconstruction
US6171610B1 (en) *	1998-04-24	2001-01-09	University Of Massachusetts	Guided development and support of hydrogel-cell compositions
EP1096941B1 (en) *	1998-05-07	2005-08-10	University Of South Florida	Bone marrow cells as a source of neurons for brain and spinal cord repair
ES2292245T3 (es)	1998-05-29	2008-03-01	Osiris Therapeutics, Inc.	Celulas madre mesenquimaticas cd45+ y/o fibroblasto+humanas.
US6323188B1 (en)	1998-07-01	2001-11-27	Donald L. Weissman	Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins
DE19833340A1 (de)	1998-07-24	2000-02-10	Karlsruhe Forschzent	Wurmförmiger Arbeitsmechanismus
US20040037818A1 (en)	1998-07-30	2004-02-26	Brand Stephen J.	Treatment for diabetes
JP4624558B2 (ja)	1998-08-10	2011-02-02	ザガバメントオブザユナイテッドステイツオブアメリカ，アズレプレゼンテッドバイザセクレタリー，デパートメントオブヘルスアンドヒューマンサービシーズ	ＧＬＰ−１またはＥｘｅｎｄｉｎ−４による、非インスリン産生細胞のインスリン産生細胞への分化、およびその使用
US5958767A (en)	1998-08-14	1999-09-28	The Children's Medical Center Corp.	Engraftable human neural stem cells
US6284245B1 (en)	1998-08-25	2001-09-04	Diacrin, Inc.	Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
US6444205B2 (en)	1998-09-30	2002-09-03	Diacrin, Inc.	Transplantation of neural cells for the treatment of chronic pain or spasticity
US6610540B1 (en)	1998-11-18	2003-08-26	California Institute Of Technology	Low oxygen culturing of central nervous system progenitor cells
US6241369B1 (en) *	1998-11-20	2001-06-05	Cooper Technologies Company	Quick mount fixture
US6144054A (en) *	1998-12-04	2000-11-07	International Business Machines Corporation	DRAM cell having an annular signal transfer region
DE19856428C1 (de) *	1998-12-08	2000-05-04	Heraeus Noblelight Gmbh	Entladungslampe
US6733433B1 (en)	1998-12-24	2004-05-11	Biosafe S.A.	Blood separation system particularly for concentrating hematopoietic stem cells
JP4932069B2 (ja)	1999-01-25	2012-05-16	株式会社セルシード	アクリルアミド誘導体および該誘導体を含む重合体
MXPA01007810A (es)	1999-02-04	2003-06-04	Univ Mcgill	Plataforma para la diferenciacion de celulas.
WO2000047720A2 (en)	1999-02-10	2000-08-17	Curis, Inc.	Pancreatic progenitor cells, methods and uses related thereto
US6592623B1 (en) *	1999-08-31	2003-07-15	Virginia Commonwealth University Intellectual Property Foundation	Engineered muscle
JP2002537849A (ja)	1999-03-10	2002-11-12	ユニヴァーシティオヴピッツバーグオヴザコモンウェルスシステムオヴハイアーエデュケーション	脂肪由来の幹細胞および格子
US20030007954A1 (en)	1999-04-12	2003-01-09	Gail K. Naughton	Methods for using a three-dimensional stromal tissue to promote angiogenesis
KR100696407B1 (ko)	1999-04-16	2007-03-19	더블유엠. 마쉬 라이스 유니버시티	폴리(프로필렌 푸마레이트)-디아크릴레이트 마크로머와가교결합된 생분해성 폴리(프로필렌 푸마레이트) 네트워크
US6261600B1 (en) *	1999-04-30	2001-07-17	Drugtech Corporation	Folic acid supplement
US6287340B1 (en) *	1999-05-14	2001-09-11	Trustees Of Tufts College	Bioengineered anterior cruciate ligament
US6372494B1 (en)	1999-05-14	2002-04-16	Advanced Tissue Sciences, Inc.	Methods of making conditioned cell culture medium compositions
WO2000073421A2 (en)	1999-06-02	2000-12-07	Lifebank Services, L.L.C.	Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
US6329904B1 (en) *	1999-06-11	2001-12-11	Safety Through Cellular, Inc.	Apparatus and method for providing weather and other alerts
US6261841B1 (en)	1999-06-25	2001-07-17	The Board Of Trustees Of Northwestern University	Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
US6333029B1 (en)	1999-06-30	2001-12-25	Ethicon, Inc.	Porous tissue scaffoldings for the repair of regeneration of tissue
US6355699B1 (en)	1999-06-30	2002-03-12	Ethicon, Inc.	Process for manufacturing biomedical foams
WO2001011011A2 (en)	1999-08-05	2001-02-15	Mcl Llc	Multipotent adult stem cells and methods for isolation
US6429013B1 (en) *	1999-08-19	2002-08-06	Artecel Science, Inc.	Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6555374B1 (en)	1999-08-19	2003-04-29	Artecel Sciences, Inc.	Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
WO2001019379A2 (en)	1999-09-14	2001-03-22	Children's Medical Center Corporation, The	Methods for treating muscular dystrophy with bone marrow cells
US6331313B1 (en)	1999-10-22	2001-12-18	Oculex Pharmaceticals, Inc.	Controlled-release biocompatible ocular drug delivery implant devices and methods
US20030129745A1 (en)	1999-10-28	2003-07-10	Robl James M.	Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
EP1099754A1 (en)	1999-11-10	2001-05-16	Universiteit Leiden	Mesenchymal stem cells and/or progenitor cells, their isolation and use
CA2392615A1 (en)	1999-12-06	2001-06-07	The General Hospital Corporation	Pancreatic stem cells and their use in transplantation
US20030082155A1 (en)	1999-12-06	2003-05-01	Habener Joel F.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US20020164307A1 (en)	1999-12-06	2002-11-07	Habener Joel F.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US7785882B2 (en)	2000-01-18	2010-08-31	Cornell Research Foundation, Inc.	Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them
US7544509B2 (en)	2000-01-24	2009-06-09	Mcgill University	Method for preparing stem cell preparations
US6610535B1 (en)	2000-02-10	2003-08-26	Es Cell International Pte Ltd.	Progenitor cells and methods and uses related thereto
DE60142553D1 (de)	2000-02-11	2010-08-26	Children S Hospital Of Orange	Isolierung und transplantation von retinalen stammzellen
CA2399623A1 (en)	2000-02-11	2001-08-16	Philadelphia Health And Education Corporation	Differentiation of bone marrow cells into neuronal cells and uses therefor
IL151650A0 (en)	2000-03-09	2003-04-10	Saneron Ccel Therapeutics Inc	Human cord blood as a source of neural tissue for repair of the brain and spinal cord
US20010053362A1 (en) *	2000-03-09	2001-12-20	Lee Walters	Applications of immune system tolerance to treatment of various diseases
EP2298858A1 (en)	2000-03-16	2011-03-23	Cellseed Inc.	Bed material for cell culture, method for co-culture of cell and co-cultured cell sheet obtainable therefrom
US6436704B1 (en)	2000-04-10	2002-08-20	Raven Biotechnologies, Inc.	Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US6673606B1 (en)	2000-04-12	2004-01-06	The Children's Hospital Of Philadelphia	Therapeutic uses for mesenchymal stromal cells
US6375972B1 (en)	2000-04-26	2002-04-23	Control Delivery Systems, Inc.	Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
IL152785A0 (en)	2000-05-12	2003-06-24	Univ Utah Res Found	Compositions and methods for cell dedifferentiation and tissue regeneration
US8273570B2 (en)	2000-05-16	2012-09-25	Riken	Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
US7049072B2 (en)	2000-06-05	2006-05-23	University Of South Florida	Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
US6759039B2 (en) *	2000-06-30	2004-07-06	Amcyte, Inc.	Culturing pancreatic stem cells having a specified, intermediate stage of development
WO2002010349A1 (fr)	2000-07-21	2002-02-07	Cellseed Inc.	Cellules epidermiques cultivees en couche mince, peau cultivee de façon stratifiee et procede de production associe
DE60143892D1 (de)	2000-07-21	2011-03-03	Cellseed Ind	Herzmuskel-ähnliche zellschicht, dreidimensionales konstrukt, herzmuskel-ähnliches gewebe und verfahren zur herstellung
US6984522B2 (en)	2000-08-03	2006-01-10	Regents Of The University Of Michigan	Isolation and use of solid tumor stem cells
DE10038814A1 (de) *	2000-08-09	2002-02-21	Abb Research Ltd	Hochspannungs-Gleichstromwandler
US7211434B2 (en)	2000-09-29	2007-05-01	Van Der Kooy Derek	Primitive neural stem cells and method for differentiation of stem cells to neural cells
US6639470B1 (en)	2000-10-06	2003-10-28	Skyworks Solutions, Inc.	Constant current biasing circuit for linear power amplifiers
US7560280B2 (en)	2000-11-03	2009-07-14	Kourion Therapeutics Gmbh	Human cord blood derived unrestricted somatic stem cells (USSC)
US20020098584A1 (en)	2000-11-06	2002-07-25	Palmer Theo D.	Postmortem stem cells
AU2001297880B2 (en)	2000-11-30	2007-05-31	Stemron Inc.	Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP1349918B1 (en)	2000-12-06	2014-08-06	Anthrogenesis Corporation	Method of collecting placental stem cells
US6599323B2 (en) *	2000-12-21	2003-07-29	Ethicon, Inc.	Reinforced tissue implants and methods of manufacture and use
CA2365376C (en)	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
AU2002239810A1 (en)	2001-01-02	2002-07-16	The Charles Stark Draper Laboratory, Inc.	Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
JP2005503759A (ja)	2001-01-24	2005-02-10	アメリカ合衆国	幹細胞の膵臓内分泌細胞への分化方法
WO2002061053A1 (en)	2001-01-31	2002-08-08	The General Hospital Corporation	Renal stem cells and uses thereof
ATE419333T1 (de)	2001-02-06	2009-01-15	Massachusetts Inst Technology	Peptidgerüstverkapselung von gewebszellen und verwendungen davon
US7449180B2 (en)	2001-02-06	2008-11-11	John Kisiday	Macroscopic scaffold containing amphiphilic peptides encapsulating cells
ES2558626T3 (es)	2001-02-14	2016-02-05	Anthrogenesis Corporation	Placenta post-parto de mamíferos, su uso y células madre placentarias de la misma
CA2438501C (en)	2001-02-14	2014-09-16	Leo T. Furcht	Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
CA2856986C (en) *	2001-02-14	2019-08-13	Anthrogenesis Corporation	Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
JP2005503120A (ja) *	2001-03-27	2005-02-03	マサチューセッツ　インスティテュート　オブ　テクノロジー	Ｆｇｆダイマー化に関する方法及び生成物
US7838292B1 (en)	2001-03-29	2010-11-23	University Of Louisville Research Foundation, Inc.	Methods for obtaining adult human olfactory progenitor cells
CA2442177A1 (en)	2001-03-29	2002-10-10	Ixion Biotechnology, Inc.	Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
US20050054102A1 (en)	2001-04-19	2005-03-10	Anna Wobus	Method for differentiating stem cells into insulin-producing cells
KR100762261B1 (ko)	2001-04-27	2007-10-04	(주)바이오니아	전장 상보 디옥시리보핵산 제조 방법과 이에 사용되는앵커와 프라이머
US20030211605A1 (en)	2001-05-01	2003-11-13	Lee Sang-Hun	Derivation of midbrain dopaminergic neurons from embryonic stem cells
US20030022369A1 (en)	2001-05-18	2003-01-30	Helen Fillmore	Differentiation of specialized dermal and epidermal cells into neuronal cells
JP2005515753A (ja)	2001-05-25	2005-06-02	サイセラ，インコーポレイテッド	幹細胞分化
US7160726B2 (en) *	2001-06-07	2007-01-09	Skin Medica, Inc.	Compositions comprising conditioned cell culture media and uses thereof
RU2183966C1 (ru)	2001-07-06	2002-06-27	Общество с ограниченной ответственностью "Сибларекс"	Состав биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий и способ получения биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий
US6402263B1 (en)	2001-07-24	2002-06-11	Robert Bosch Corporation	Dual actuation master cylinder
CA2463930A1 (en) *	2001-08-08	2003-02-20	Celmed Biosciences Usa, Inc.	Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
US20030211603A1 (en)	2001-08-14	2003-11-13	Earp David J.	Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
AU2002313817A1 (en)	2001-08-27	2003-03-10	Advanced Cell Technology, Inc.	Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
US20030104997A1 (en)	2001-09-05	2003-06-05	Black Ira B.	Multi-lineage directed induction of bone marrow stromal cell differentiation
CN1195055C (zh)	2001-09-06	2005-03-30	周胜利	从胎盘组织中提取造血干细胞用于建立造血干细胞库的新方法
US20050064587A1 (en)	2001-09-07	2005-03-24	Lawrence Rosenberg	Pancreatic small cells and uses thereof
US9969980B2 (en)	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
EP1298201A1 (en)	2001-09-27	2003-04-02	Cardion AG	Process for the production of cells exhibiting an islet-beta-cell-like state
US7072332B2 (en) *	2001-09-27	2006-07-04	Samsung Electronics Co., Ltd.	Soft switch using distributed firewalls for load sharing voice-over-IP traffic in an IP network
JP2005503822A (ja)	2001-09-28	2005-02-10	イーエス・セル・インターナショナル・プライヴェート・リミテッド	無フィーダーマトリックス上での未分化ヒト胚性幹（ｈｅｓ）細胞の導出および増殖方法ならびにヒトフィーダー層
JP2005506074A (ja)	2001-10-18	2005-03-03	イクシオン・バイオテクノロジー・インコーポレーテッド	肝臓の幹細胞および前駆細胞の膵臓機能細胞への転換
US7129034B2 (en)	2001-10-25	2006-10-31	Cedars-Sinai Medical Center	Differentiation of whole bone marrow
CZ2004696A3 (cs)	2001-11-09	2005-02-16	Artecel Sciences, Inc.	Endokrinní pankreatická diferenciace buněk stromatu odvozených z adipózní tkáně a její použití
WO2003054146A2 (en)	2001-11-14	2003-07-03	Northwestern University	Self-assembly and mineralization of peptide-amphiphile nanofibers
CA2468171C (en)	2001-11-15	2015-10-06	Children's Medical Center Corporation	Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
JP3728750B2 (ja)	2001-11-22	2005-12-21	ニプロ株式会社	培養皮膚及びその製造方法
JP4441263B2 (ja)	2001-11-28	2010-03-31	アンジェスＭｇ株式会社	神経変性疾患遺伝子治療剤
US6712850B2 (en)	2001-11-30	2004-03-30	Ethicon, Inc.	Porous tissue scaffolds for the repair and regeneration of dermal tissue
AU2002351238B2 (en)	2001-12-04	2009-01-08	Organogenesis Inc.	Cultured cells from pancreatic islets
WO2003054171A1 (en)	2001-12-06	2003-07-03	The Regents Of The University Of California	Method for differentiating islet precursor cells into beta cells
AU2002354101A1 (en) *	2001-12-06	2003-06-17	Sankyo Company, Limited	Medicinal compositions containing human amnion-origin cells
IL162131A0 (en) *	2001-12-07	2005-11-20	Geron Corp	Islet cells from human embryonic stem cells
AU2002364558A1 (en)	2001-12-11	2003-06-23	Cytograft Tissue Engineering, Inc.	Tissue engineered cellular sheets, methods of making and use thereof
JP3934539B2 (ja)	2001-12-12	2007-06-20	独立行政法人科学技術振興機構	胎盤等由来の成体又は生後組織の前駆細胞
US20030113910A1 (en)	2001-12-18	2003-06-19	Mike Levanduski	Pluripotent stem cells derived without the use of embryos or fetal tissue
DE60236016D1 (de) *	2001-12-21	2010-05-27	Mount Sinai Hospital Corp	Zelluläre zusammensetzungen und verfahren zur deren bereitung und verwendung
US7101546B2 (en)	2001-12-21	2006-09-05	Amcyte, Inc.	In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
IL162663A0 (en)	2001-12-28	2005-11-20	Cellartis Ab	A method for the establishment of apluripotent human blastocyst-derived stem cell line
AU2003202988A1 (en)	2002-01-14	2003-07-30	The Board Of Trustees Of The University Of Illinois	Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US20030158089A1 (en) *	2002-01-24	2003-08-21	Xenoport, Inc.	Administrative agents via the SMVT transporter
US20030162290A1 (en)	2002-01-25	2003-08-28	Kazutomo Inoue	Method for inducing differentiation of embryonic stem cells into functioning cells
AU2003217357A1 (en)	2002-02-07	2003-09-02	The Research Foundation Of The State University Of New York	Generation of new insulin cells from progenitor cells present in adult pancreatic islets
KR101176146B1 (ko)	2002-02-13	2012-08-22	안트로제네시스 코포레이션	산후 포유류 태반으로부터 유래한 배아-유사 줄기 세포와그 세포를 사용한 용도 및 치료방법
US7576065B2 (en)	2002-02-15	2009-08-18	Cornell Research Foundation, Inc.	Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
US7371719B2 (en)	2002-02-15	2008-05-13	Northwestern University	Self-assembly of peptide-amphiphile nanofibers under physiological conditions
WO2003070922A1 (en)	2002-02-19	2003-08-28	Medipost Co., Ltd.	Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US7029915B2 (en)	2002-02-22	2006-04-18	University Of Florida Research Foundation, Inc.	Method for differentiating rat hepatic stem cells to insulin-producing cells
US7736892B2 (en) *	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
US20030161818A1 (en) *	2002-02-25	2003-08-28	Kansas State University Research Foundation	Cultures, products and methods using stem cells
US7150990B2 (en)	2002-03-06	2006-12-19	Reprocell, Inc.	Self-renewing pluripotent hepatic stem cells
JP2003259862A (ja)	2002-03-12	2003-09-16	Fuji Photo Film Co Ltd	細胞培養担体
WO2003080822A1 (en)	2002-03-27	2003-10-02	Nipro Corporation	Placenta-origin mesenchymal cells and medicinal use thereof
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
AU2003262187A1 (en)	2002-04-12	2003-10-27	Celgene Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
JP4136434B2 (ja)	2002-04-17	2008-08-20	進清野	インスリン産生細胞の誘導
EP1497435A4 (en)	2002-04-19	2005-07-27	Univ Pittsburgh	STEM CELLS DERIVED FROM PLAZENTA AND THEIR USES
US20040161419A1 (en)	2002-04-19	2004-08-19	Strom Stephen C.	Placental stem cells and uses thereof
US20030228295A1 (en)	2002-04-25	2003-12-11	Svendsen Clive N.	Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
US20040029269A1 (en)	2002-05-07	2004-02-12	Goldman Steven A	Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells
WO2003094965A2 (en)	2002-05-08	2003-11-20	Neuronova Ab	Modulation of neural stem cells with s1p or lpa receptor agonists
JP2005527241A (ja)	2002-05-28	2005-09-15	ベクトン・ディキンソン・アンド・カンパニー	ｉｎｖｉｔｒｏにおけるヒト膵臓腺房細胞の増殖およびインスリン産生細胞への分化転換のための方法
EP1525308A4 (en)	2002-05-30	2006-11-02	Celgene Corp	METHODS OF USING JNK OR MKK INHIBITORS TO MODULATE CELL DIFFERENTIATION AND TREAT MYELOPROLIFERATIVE DISORDERS AND MYELODYSPLASIC SYNDROMES
WO2003104442A1 (en)	2002-06-07	2003-12-18	Es Cell International Pte Ltd	Methods of regulating differentiation in stem cells
WO2003104423A2 (en)	2002-06-11	2003-12-18	Roy Ogle	Meningeal-derived stem cells
AU2003279912A1 (en)	2002-06-27	2004-01-19	Northwestern University	Peptide rod amphiphiles and self-assembly of same
US7285415B2 (en)	2002-07-11	2007-10-23	The Regents Of The University Of California	Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
GB0216286D0 (en)	2002-07-15	2002-08-21	Univ Leeds	Network
JP2005532810A (ja)	2002-07-16	2005-11-04	イッサムリサーチディベロップメントカンパニーオブザヘブリューユニバーシティーオブエルサレム	組織修復および組織形成のために間葉性幹細胞を移植する方法
US7390659B2 (en)	2002-07-16	2008-06-24	The Trustees Of Columbia University In The City Of New York	Methods for inducing differentiation of embryonic stem cells and uses thereof
AU2003250666A1 (en)	2002-07-29	2004-02-16	Asahi Kasei Kabushiki Kaisha	Stem cells for treating pancreatic damage
WO2004011621A2 (en)	2002-07-29	2004-02-05	Es Cell International Pte Ltd.	Multi-step method for the differentiation of insulin positive, glucose
US20040063204A1 (en)	2002-08-14	2004-04-01	Lijun Yang	Bone marrow cell differentiation
WO2004018655A2 (en) *	2002-08-26	2004-03-04	Neuronova Ab	Method for culturing stem cells
JP2006508648A (ja)	2002-08-28	2006-03-16	ユニヴァーシティオヴフロリダ	肝幹細胞からの神経新生
EP1539928A4 (en)	2002-09-06	2006-09-06	Amcyte Inc	CD56-POSITIVE HUMAN ADULTS PANCREATIC ENDOCRINE PRECURSOR CELLS
US6766863B2 (en) *	2002-09-20	2004-07-27	Hypro Corporation	Fire fighting foam injection system with auto-start feature
US9969977B2 (en)	2002-09-20	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US20040062753A1 (en)	2002-09-27	2004-04-01	Alireza Rezania	Composite scaffolds seeded with mammalian cells
JP4262465B2 (ja)	2002-10-24	2009-05-13	富士フイルム株式会社	細胞培養方法
WO2004039248A2 (en)	2002-10-31	2004-05-13	The General Hospital Corporation	Repairing or replacing tissues or organs
US20040258670A1 (en)	2002-12-05	2004-12-23	Case Western Reserve University	Cell-based therapies for ischemia
JP4571387B2 (ja)	2003-02-07	2010-10-27	宣男櫻川	ヒト羊膜由来サイドポピュレーション細胞及びその用途
AU2004210853A1 (en)	2003-02-11	2004-08-26	Northwestern University	Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
EP2277992A3 (en) *	2003-02-11	2011-03-02	John E. Davies	Progenitor cells from Wharton's jelly of human umbilical cord
US7521481B2 (en) *	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2006019366A1 (en)	2003-03-28	2006-02-23	Wisconsin Alumni Research Foundation	Physiochemical culture conditions for embryonic stem cells
WO2005034624A2 (en)	2003-05-21	2005-04-21	The General Hospital Corporation	Microfabricated compositions and processes for engineering tissues containing multiple cell types
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
ES2564044T3 (es)	2003-06-27	2016-03-17	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
EP1660644A1 (en)	2003-08-29	2006-05-31	Regents Of The University Of Minnesota	Kidney derived stem cells and methods for their isolation, differentiation and use
US20050089513A1 (en) *	2003-10-28	2005-04-28	Norio Sakuragawa	Side population cells originated from human amnion and their uses
MXPA06006930A (es) *	2003-12-23	2007-01-26	Fmc Biopolymer As	Uso de matrices de alginato para controlar la proliferacion celular.
TWI276685B (en)	2003-12-30	2007-03-21	Ind Tech Res Inst	Conditional medium for culturing Schwann cells
US7534606B2 (en)	2004-01-12	2009-05-19	National Health Research Institutes	Placental stem cell and methods thereof
DE102004043256B4 (de)	2004-09-07	2013-09-19	Rheinische Friedrich-Wilhelms-Universität Bonn	Skalierbarer Prozess zur Kultivierung undifferenzierter Stammzellen in Suspension
US8039258B2 (en)	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
JP2008518597A (ja)	2004-10-29	2008-06-05	セントカー・インコーポレーテツド	化学的規定培地組成物
US7655678B2 (en) *	2004-11-30	2010-02-02	Council of Scientfic & Industrial Research	Pharmaceutical composition for the management of tumors
WO2006101548A2 (en)	2004-12-21	2006-09-28	Ethicon, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060153815A1 (en)	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
WO2006083394A2 (en)	2004-12-21	2006-08-10	Ethicon, Inc.	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
EP1831355A2 (en)	2004-12-23	2007-09-12	Ethicon, Inc.	Soft tissue repair and regeneration using postpartum-derived cells and cell products
WO2006071778A2 (en)	2004-12-23	2006-07-06	Ethicon Incorporated	Treatment of parkinson's disease and related disorders using postpartum derived cells
EP1838842A2 (en)	2004-12-23	2007-10-03	Ethicon, Incorporated	Treatment of osteochondral diseases using postpartum-derived cells and products thereof
ES2621847T3 (es)	2004-12-23	2017-07-05	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
US7741311B2 (en)	2005-01-03	2010-06-22	Shaker Mousa	Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
AU2006208944A1 (en)	2005-01-28	2006-08-03	Imperial College Innovations Limited	Methods for embryonic stem cell culture
EP2460875A1 (en)	2005-03-31	2012-06-06	Stemnion, Inc.	Amnion-derived cell compositions, methods of making and uses thereof
US7923007B2 (en)	2005-08-08	2011-04-12	Academia Sinica	Brain tissue damage therapies
EP1971681B1 (en)	2005-12-16	2017-08-23	DePuy Synthes Products, Inc.	Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US8741638B2 (en)	2005-12-19	2014-06-03	DePuy Synthes Products, LLC	In vitro expansion of postpartum-derived cells in roller bottles
JP5599568B2 (ja)	2005-12-28	2014-10-01	エシコン・インコーポレイテッド	分娩後由来細胞を用いた末梢血管疾患の治療
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
EP2471907B1 (en) *	2005-12-29	2018-09-26	Celularity, Inc.	Placental stem cell populations
US7939645B2 (en) *	2006-01-06	2011-05-10	Agilent Technologies, Inc	Reaction buffer composition for nucleic acid replication with packed DNA polymerases
KR101490449B1 (ko)	2006-03-23	2015-02-05	플루리스템 리미티드	세포 증식 방법 및 세포의 용도 및 치료를 위해 그 세포에 의해 제조되는 조절된 배지
WO2007146105A2 (en) *	2006-06-05	2007-12-21	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
AU2007308168B2 (en)	2006-10-12	2013-09-26	Ethicon, Inc.	Kidney-derived cells and methods of use in tissue repair and regeneration
AU2007319820B2 (en)	2006-11-13	2013-09-05	Ethicon, Incorporated	In vitro expansion of postpartum-derived cells using microcarriers
KR20150039214A (ko) *	2007-02-12	2015-04-09	안트로제네시스 코포레이션	태반 줄기세포를 이용한 염증 질환의 치료
US20080305148A1 (en)	2007-03-19	2008-12-11	National Yang Ming University	Treatment of spinal injuries using human umbilical mesenchymal stem cells
CN102036688B (zh)	2007-10-05	2014-07-02	伊西康公司	使用人脐带组织来源的细胞进行肾脏组织的修复和再生
US20090123620A1 (en) *	2007-11-14	2009-05-14	Hiti Thomas R	Automated Application of an Antimycotic Composition to Sliced Foodstuffs and an Antimycotic Application Apparatus
US8236538B2 (en)	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
WO2009086215A2 (en)	2007-12-21	2009-07-09	Wyeth	Pathway analysis of cell culture phenotypes and uses thereof
UA99167C2 (ru)	2007-12-27	2012-07-25	Этикон, Инкорпорейтед	Лечение дегенерации межреберных дисков с использованием клеток, полученных из ткани пуповины человека
TWI363851B (en) *	2008-03-28	2012-05-11	Ind Tech Res Inst	Lighting device and assembling method thereof
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
CN107028983A (zh)	2008-12-19	2017-08-11	德普伊新特斯产品有限责任公司	肺部疾病和病症的治疗
EP2379089B1 (en)	2008-12-19	2019-04-17	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue following injury
AU2009327382B2 (en)	2008-12-19	2014-07-17	DePuy Synthes Products, LLC	Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
EP2411504B1 (en)	2009-03-26	2017-05-10	DePuy Synthes Products, Inc.	Human umbilical cord tissue cells as therapy for alzheimer's disease
CN103329308B (zh) *	2011-01-19	2016-09-14	纳幕尔杜邦公司	具有关闭功能的锂电池隔板

2004
- 2004-06-25 ES ES04756395.2T patent/ES2564044T3/es not_active Expired - Lifetime
- 2004-06-25 CA CA2530422A patent/CA2530422C/en not_active Expired - Fee Related
- 2004-06-25 CA CA2530255A patent/CA2530255C/en not_active Expired - Fee Related
- 2004-06-25 ES ES04777234.8T patent/ES2600555T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP10183053.7A patent/EP2399990B1/en not_active Expired - Lifetime
- 2004-06-25 US US10/877,009 patent/US7560276B2/en not_active Expired - Lifetime
- 2004-06-25 US US10/877,446 patent/US9579351B2/en not_active Expired - Fee Related
- 2004-06-25 WO PCT/US2004/020823 patent/WO2005001078A2/en not_active Ceased
- 2004-06-25 PL PL04777287T patent/PL1641918T3/pl unknown
- 2004-06-25 CA CA2530533A patent/CA2530533C/en not_active Expired - Fee Related
- 2004-06-25 PL PL04777234T patent/PL1641915T3/pl unknown
- 2004-06-25 JP JP2006517786A patent/JP4948164B2/ja not_active Expired - Fee Related
- 2004-06-25 ES ES10184593.1T patent/ES2542070T3/es not_active Expired - Lifetime
- 2004-06-25 US US10/877,541 patent/US7413734B2/en not_active Expired - Lifetime
- 2004-06-25 AU AU2004252567A patent/AU2004252567B2/en not_active Ceased
- 2004-06-25 AU AU2004252566A patent/AU2004252566B2/en not_active Ceased
- 2004-06-25 PL PL10183911T patent/PL2341131T3/pl unknown
- 2004-06-25 EP EP10184306.8A patent/EP2338982B1/en not_active Expired - Lifetime
- 2004-06-25 US US10/877,269 patent/US7524489B2/en not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020957 patent/WO2005001080A2/en not_active Ceased
- 2004-06-25 US US10/876,998 patent/US11191789B2/en not_active Expired - Fee Related
- 2004-06-25 AU AU2004252568A patent/AU2004252568B2/en not_active Expired - Fee Related
- 2004-06-25 EP EP04777286.8A patent/EP1641917B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517788A patent/JP4948166B2/ja not_active Expired - Fee Related
- 2004-06-25 EP EP04777287.6A patent/EP1641918B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530732A patent/CA2530732C/en not_active Expired - Fee Related
- 2004-06-25 EP EP20100184221 patent/EP2338981B1/en not_active Expired - Lifetime
- 2004-06-25 ES ES04809466.8T patent/ES2565582T3/es not_active Expired - Lifetime
- 2004-06-25 JP JP2006517787A patent/JP4948165B2/ja not_active Expired - Fee Related
- 2004-06-25 PL PL10184306T patent/PL2338982T3/pl unknown
- 2004-06-25 EP EP10184796.0A patent/EP2336298B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530412A patent/CA2530412C/en not_active Expired - Fee Related
- 2004-06-25 JP JP2006517760A patent/JP4950661B2/ja not_active Expired - Fee Related
- 2004-06-25 ES ES04777231.4T patent/ES2597837T3/es not_active Expired - Lifetime
- 2004-06-25 PL PL10184221T patent/PL2338981T3/pl unknown
- 2004-06-25 PL PL04777286.8T patent/PL1641917T3/pl unknown
- 2004-06-25 ES ES10184796.0T patent/ES2569780T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES04777286.8T patent/ES2582342T3/es not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020931 patent/WO2005003334A2/en not_active Ceased
- 2004-06-25 PL PL10184796T patent/PL2336298T3/pl unknown
- 2004-06-25 PL PL04809466T patent/PL1649013T3/pl unknown
- 2004-06-25 PL PL10184137T patent/PL2338980T3/pl unknown
- 2004-06-25 ES ES04777235.5T patent/ES2568463T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP10183911.6A patent/EP2341131B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530416A patent/CA2530416C/en not_active Expired - Fee Related
- 2004-06-25 JP JP2006517759A patent/JP4950660B2/ja not_active Expired - Fee Related
- 2004-06-25 JP JP2006517757A patent/JP4950659B2/ja not_active Expired - Fee Related
- 2004-06-25 PL PL04777231T patent/PL1641914T3/pl unknown
- 2004-06-25 WO PCT/US2004/020822 patent/WO2005001077A2/en not_active Ceased
- 2004-06-25 EP EP04777235.5A patent/EP1641916B1/en not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020958 patent/WO2005038012A2/en not_active Ceased
- 2004-06-25 WO PCT/US2004/020816 patent/WO2005001076A2/en not_active Ceased
- 2004-06-25 ES ES10184221.9T patent/ES2541604T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES10184137.7T patent/ES2542069T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP10184593.1A patent/EP2322599B1/en not_active Expired - Lifetime
- 2004-06-25 ES ES10184306.8T patent/ES2554343T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004281371A patent/AU2004281371C1/en not_active Ceased
- 2004-06-25 PL PL04777235T patent/PL1641916T3/pl unknown
- 2004-06-25 PL PL04756395T patent/PL1641913T3/pl unknown
- 2004-06-25 EP EP04809466.8A patent/EP1649013B1/en not_active Expired - Lifetime
- 2004-06-25 ES ES04777287.6T patent/ES2564045T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004254616A patent/AU2004254616C1/en not_active Ceased
- 2004-06-25 US US10/877,012 patent/US7510873B2/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530421A patent/CA2530421C/en not_active Expired - Fee Related
- 2004-06-25 PL PL10183053T patent/PL2399990T3/pl unknown
- 2004-06-25 AU AU2004252571A patent/AU2004252571C1/en not_active Ceased
- 2004-06-25 ES ES10183053.7T patent/ES2550267T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES10183911.6T patent/ES2552226T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP20100184137 patent/EP2338980B1/en not_active Expired - Lifetime
- 2004-06-25 EP EP04756395.2A patent/EP1641913B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517783A patent/JP5148873B2/ja not_active Expired - Fee Related
- 2004-06-25 US US10/877,445 patent/US8703121B2/en active Active
- 2004-06-25 EP EP04777234.8A patent/EP1641915B1/en not_active Expired - Lifetime
- 2004-06-25 AU AU2004252570A patent/AU2004252570C1/en not_active Ceased
- 2004-06-25 EP EP04777231.4A patent/EP1641914B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL10184593T patent/PL2322599T3/pl unknown
- 2004-06-25 WO PCT/US2004/020956 patent/WO2005001079A2/en not_active Ceased
2005
- 2005-12-22 US US11/316,104 patent/US9504719B2/en not_active Expired - Fee Related
- 2005-12-22 US US11/315,969 patent/US11179422B2/en not_active Expired - Fee Related
- 2005-12-23 US US11/317,574 patent/US20060234376A1/en not_active Abandoned
- 2005-12-29 US US11/321,864 patent/US20060153818A1/en not_active Abandoned
- 2005-12-29 US US11/321,863 patent/US20060153817A1/en not_active Abandoned
- 2005-12-29 US US11/322,003 patent/US20060154367A1/en not_active Abandoned
- 2005-12-30 US US11/322,372 patent/US20060188983A1/en not_active Abandoned
2006
- 2006-07-06 US US11/481,480 patent/US20070009494A1/en not_active Abandoned
- 2006-07-06 US US11/481,456 patent/US8318483B2/en not_active Expired - Fee Related
- 2006-07-06 US US11/481,481 patent/US20070014771A1/en not_active Abandoned
2009
- 2009-02-19 US US12/389,305 patent/US9498501B2/en not_active Expired - Fee Related
- 2009-04-24 US US12/429,849 patent/US8277796B2/en not_active Expired - Fee Related
2012
- 2012-09-06 US US13/605,716 patent/US8658152B2/en not_active Expired - Lifetime
2013
- 2013-09-05 US US14/018,842 patent/US9717763B2/en not_active Expired - Fee Related
2016
- 2016-11-28 US US15/362,453 patent/US10039793B2/en not_active Expired - Lifetime
2017
- 2017-02-27 US US15/443,733 patent/US10383898B2/en not_active Expired - Fee Related
- 2017-02-27 US US15/443,718 patent/US10195233B2/en not_active Expired - Lifetime
- 2017-02-27 US US15/443,602 patent/US10220059B2/en not_active Expired - Lifetime
- 2017-07-27 US US15/661,878 patent/US10500234B2/en not_active Expired - Fee Related
2018
- 2018-08-06 US US16/056,146 patent/US10758576B2/en not_active Expired - Fee Related
2019
- 2019-03-04 US US16/291,784 patent/US11000554B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1641918B1 (en)	2016-01-06
EP2338981A2 (en)	2011-06-29
JP4948165B2 (ja)	2012-06-06
US20060153816A1 (en)	2006-07-13
EP2338981B1 (en)	2015-04-22
JP2007521008A (ja)	2007-08-02
PL2338981T3 (pl)	2016-01-29
PL2341131T3 (pl)	2016-01-29
JP2007528703A (ja)	2007-10-18
US20050058630A1 (en)	2005-03-17
AU2004254616A1 (en)	2005-01-13
JP4948164B2 (ja)	2012-06-06
US20100210013A1 (en)	2010-08-19
EP2338980A2 (en)	2011-06-29
EP2322599B1 (en)	2015-04-15
US10039793B2 (en)	2018-08-07
ES2564044T3 (es)	2016-03-17
EP1641916A2 (en)	2006-04-05
PL1649013T3 (pl)	2016-07-29
EP2338980B1 (en)	2015-04-22
US20170166864A1 (en)	2017-06-15
EP2336298B1 (en)	2016-02-17
EP2338982B1 (en)	2015-08-26
PL2336298T3 (pl)	2016-08-31
US20170166863A1 (en)	2017-06-15
EP2341131B1 (en)	2015-08-05
EP2399990B1 (en)	2015-07-22
US20170239299A1 (en)	2017-08-24
AU2004281371B2 (en)	2012-05-10
WO2005001078A2 (en)	2005-01-06
US20070014771A1 (en)	2007-01-18
US7560276B2 (en)	2009-07-14
AU2004254616C1 (en)	2012-03-01
EP2322599A2 (en)	2011-05-18
AU2004281371C1 (en)	2012-10-11
JP4948166B2 (ja)	2012-06-06
US8318483B2 (en)	2012-11-27
US8277796B2 (en)	2012-10-02
ES2568463T3 (es)	2016-04-29
EP2338980A3 (en)	2011-08-10
PL1641917T3 (pl)	2016-11-30
WO2005001077A2 (en)	2005-01-06
US7510873B2 (en)	2009-03-31
AU2004252571B2 (en)	2011-09-15
EP2338982A2 (en)	2011-06-29
PL2338980T3 (pl)	2016-04-29
US20190192577A1 (en)	2019-06-27
AU2004252566A1 (en)	2005-01-06
CA2530422A1 (en)	2005-01-06
US7524489B2 (en)	2009-04-28
CA2530255A1 (en)	2005-01-06
US10758576B2 (en)	2020-09-01
CA2530422C (en)	2016-01-05
PL2338982T3 (pl)	2016-01-29
ES2565582T3 (es)	2016-04-05
JP2007528706A (ja)	2007-10-18
CA2530533A1 (en)	2005-01-13
EP1641917B1 (en)	2016-04-27
PL1641913T3 (pl)	2016-06-30
PL2399990T3 (pl)	2015-12-31
US20060234376A1 (en)	2006-10-19
US7413734B2 (en)	2008-08-19
ES2542070T3 (es)	2015-07-30
ES2554343T3 (es)	2015-12-18
EP2338982A3 (en)	2011-08-03
US20170143770A1 (en)	2017-05-25
PL1641914T3 (pl)	2017-01-31
AU2004252566B2 (en)	2011-09-15
AU2004252568B2 (en)	2011-06-30
AU2004252567B2 (en)	2011-10-06
CA2530732C (en)	2015-03-31
EP2341131A2 (en)	2011-07-06
CA2530421A1 (en)	2005-01-06
AU2004254616B2 (en)	2011-09-01
EP1641918A2 (en)	2006-04-05
EP2322599A3 (en)	2011-07-27
WO2005001079A2 (en)	2005-01-06
US20070036767A1 (en)	2007-02-15
WO2005003334A2 (en)	2005-01-13
US20050037491A1 (en)	2005-02-17
EP1641915A2 (en)	2006-04-05
US8658152B2 (en)	2014-02-25
EP1641915B1 (en)	2016-07-27
CA2530416A1 (en)	2005-01-06
ES2552226T3 (es)	2015-11-26
JP4950661B2 (ja)	2012-06-13
WO2005001079A3 (en)	2005-04-28
US11000554B2 (en)	2021-05-11
EP2341131A3 (en)	2011-08-03
US10500234B2 (en)	2019-12-10
EP2336298A3 (en)	2011-08-03
PL1641916T3 (pl)	2016-08-31
EP1649013A2 (en)	2006-04-26
US9717763B2 (en)	2017-08-01
ES2600555T3 (es)	2017-02-09
ES2542069T3 (es)	2015-07-30
AU2004252570B2 (en)	2011-09-15
US20060153817A1 (en)	2006-07-13
US20060154366A1 (en)	2006-07-13
US10220059B2 (en)	2019-03-05
AU2004252571A1 (en)	2005-01-06
US11191789B2 (en)	2021-12-07
CA2530421C (en)	2015-04-21
AU2004252568A1 (en)	2005-01-06
JP4950659B2 (ja)	2012-06-13
JP2007521793A (ja)	2007-08-09
US20060153818A1 (en)	2006-07-13
CA2530412A1 (en)	2005-04-28
US20170326183A1 (en)	2017-11-16
US20050058631A1 (en)	2005-03-17
JP2007521009A (ja)	2007-08-02
WO2005001078A3 (en)	2005-04-21
EP2336298A2 (en)	2011-06-22
CA2530533C (en)	2015-02-10
US20050019865A1 (en)	2005-01-27
ES2550267T3 (es)	2015-11-05
JP5148873B2 (ja)	2013-02-20
PL1641918T3 (pl)	2016-06-30
US11179422B2 (en)	2021-11-23
WO2005001080A3 (en)	2005-03-24
US20140045263A1 (en)	2014-02-13
WO2005003334A3 (en)	2005-04-07
ES2541604T3 (es)	2015-07-22
ES2582342T3 (es)	2016-09-12
JP2007528702A (ja)	2007-10-18
WO2005001080A2 (en)	2005-01-06
WO2005038012A3 (en)	2005-09-15
EP1641913A2 (en)	2006-04-05
AU2004252570C1 (en)	2012-03-01
US20050054098A1 (en)	2005-03-10
ES2569780T3 (es)	2016-05-12
WO2005001077A3 (en)	2005-03-03
EP1649013B1 (en)	2016-01-20
JP2007528705A (ja)	2007-10-18
WO2005001076A2 (en)	2005-01-06
US20100260843A1 (en)	2010-10-14
US9579351B2 (en)	2017-02-28
EP2399990A1 (en)	2011-12-28
CA2530416C (en)	2015-08-25
EP2338981A3 (en)	2011-08-03
US10195233B2 (en)	2019-02-05
CA2530255C (en)	2015-12-08
ES2564045T3 (es)	2016-03-17
US10383898B2 (en)	2019-08-20
EP1641914A2 (en)	2006-04-05
PL2322599T3 (pl)	2015-10-30
AU2004252567A1 (en)	2005-01-06
US20180338999A1 (en)	2018-11-29
JP4950660B2 (ja)	2012-06-13
EP1641916B1 (en)	2016-02-17
ES2597837T3 (es)	2017-01-23
AU2004281371A1 (en)	2005-04-28
US9498501B2 (en)	2016-11-22
CA2530412C (en)	2016-02-09
AU2004252571C1 (en)	2012-03-01
US20070009494A1 (en)	2007-01-11
WO2005001076A3 (en)	2005-03-31
US20050058629A1 (en)	2005-03-17
US20060188983A1 (en)	2006-08-24
US9504719B2 (en)	2016-11-29
US20130022585A1 (en)	2013-01-24
US20050032209A1 (en)	2005-02-10
WO2005038012A2 (en)	2005-04-28
EP1641913B1 (en)	2016-01-06
CA2530732A1 (en)	2005-01-06
AU2004252570A1 (en)	2005-01-06
US20060154367A1 (en)	2006-07-13
EP1641914B1 (en)	2016-07-20
US8703121B2 (en)	2014-04-22
EP1641917A2 (en)	2006-04-05

Publication	Publication Date	Title
PL1641915T3 (pl)	2017-01-31	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo
IL179700A0 (en)	2007-05-15	Ocular implant and methods for making and using same
GB0404345D0 (en)	2004-03-31	Surgical jig and methods of use
CL2003002417A1 (es)	2004-08-27	Tratamiento de tejido con celulas mesenquimales indifereenciadas
AU2003259055A8 (en)	2004-02-25	Cell and tissue culture device
AU2003286612A1 (en)	2004-08-13	Satiation implants and methods of use
EP1485464A4 (en)	2006-11-29	METHODS OF INDUCING DIFFERENTIATION IN EX VIVO EXPANDED STEM CELLS
ZA200602379B (en)	2009-10-28	Soft tissue implants and anti-scarring agents
AU2003207698A8 (en)	2005-10-20	Needle-suture combinations and methods of use
ZA200410409B (en)	2006-05-31	Use of thio-oxindole derivatives in treatment of hormonerelated conditions
DK1517988T3 (da)	2013-07-22	Anvendelse af erythropoietin til vævsregenerering in vivo
AU2003254677A8 (en)	2004-02-25	Innervated artificial tissues and uses thereof
PL1641394T3 (pl)	2013-01-31	Sposób i urządzenie związane z testowaniem implantów
EP1702494A4 (en)	2010-11-03	DELAYED STIMULATION IN MUSHROOMS
EP1591127A4 (en)	2009-09-02	REGENERATION AND NEOGENESIS OF RETINAL SEA CELLS WITH OTX2 GEN
GB2403908B (en)	2007-03-28	Artificial cornea
EP1736173A4 (en)	2009-12-16	MEANS FOR THE TREATMENT OF TISSUE DAMAGE AND THERAPEUTIC PROCEDURE
AU2003269914A8 (en)	2003-12-02	Kit and method in eye surgery
GB0325277D0 (en)	2003-12-03	Surgical instruments for use in the implantation of tissue repair kit
AU2004229218B2 (en)	2009-05-07	Thorium-227 for use in radiotherapy of soft tissue disease
EP1812032A4 (en)	2009-09-02	TISSUE FACTOR COMPOSITION AND RELATED METHODS
AU2003249345A1 (en)	2004-01-06	Tissue reconstruction and regeneration
GB0321885D0 (en)	2003-10-22	Surgical instrument and method
PT1706094T (pt)	2018-10-29	Tratamento de condições oftalmológicas
IL163991A0 (en)	2005-12-18	Methods of inducing differentiation in ex vivo expanded stem cells